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Abstract

Purpose and Rationale: This project is designed to translate the collective knowledge and
evidence-based interventions surrounding the reduction of central line-associated bloodstream
infections (CLABSIs) and use these evidence-based practices to create an extracorporeal
membrane oxygenation (ECMO) cannula site bundle. The desired outcome of creating an ECMO
cannula-site bundle is increased cannula site integrity, decreased frequency of dressing changes,
and minimized risk of cannula-site infections.
Synthesis of Evidence: Currently, there are no clinical practice guidelines for ECMO cannula
site care to guide bedside practice. The ELSO Infectious Disease Taskforce recommends
implementation of a CLABSI bundle for ECMO site care, but many of the products used for
CLABSI prevention are not intended for large ECMO cannula sites.
Practice Change and Implementation Strategies: The DNP students will create an ECMO
cannula site bundle inspired by the CLABSI evidence available, as there is currently no ECMO
specific products available.
Evaluation: To evaluate project success, the DNP students will investigate the number of
dressing changes required for ECMO insertion sites due to saturated and/or not intact dressings
comparing pre and post implementation cohorts.
Conclusion and Implications for Practice: This project would serve as a mean to standardize
approaches to dressing the ECMO cannula insertion site, and potential serve as a clinical practice
guideline to cannula site care.
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Introduction

Extracorporeal membrane oxygenation (ECMO) programs have grown in number
internationally. The Extracorporeal Life Support Organization (ELSO) is a consortium of
ECMO centers worldwide that registers ECMO-related data and offers clinical guidance for the
ECMO population. According to ELSO, in 2010 there were 183 ECMO registered centers
totaling 3,445 patients receiving ECMO therapy. In 2019, there were 463 registered ECMO
registered centers caring for nearly 16,000 ECMO patients (ELSO, 2020). Despite this 4-fold
increase in ECMO patients worldwide over the last decade, there has been minimal evidence
published to guide the nurse in ECMO-related cares, particularly maintaining the integrity of the
cannula insertion site dressing and preventing cannula related infections (CRI). Currently, there
are no clinical practice guidelines addressing ECMO cannula site care practices, the frequency of
dressing changes, or appropriate dressings. ELSO recommends that all cannula insertion sites
are managed the same as any central line, and to implement hospital-based central line policy for
cannula site care (ELSO Infectious Disease Task Force, 2019).
A lack of clinical practice guidelines to support the bedside nurse results in a wide
variation in practice to clean and dress the cannula insertion site. This discontinuity in procedure
and lack of policy to encourage best practice causes challenges in determining the most effective
strategies for anchoring and dressing the ECMO cannula site. This literature review will
investigate the best suited materials for adequately dressing and anchoring ECMO cannula
insertion sites by analyzing central line associated bloodstream infections (CLABSI) data and
clinical practice guidelines and investigating the limited data on CRI prevention methods.

ECMO CANNULA CARE BUNDLE

6

ECMO Cannulation Approaches and Oxygenation Methods
There are two modalities for ECMO: venovenous (VV) and venoarterial (VA). VA
ECMO supports the heart and lungs of the patient by draining from a large vein and returning
richly oxygenated blood into a large artery. VA ECMO allows for the patient with a severely
decreased ejection fraction to circulate oxygen-rich blood without the assistance of the heart.
VA ECMO patients are most typically cannulated in the following sites: bifemoral sites, a
singular femoral site, and central cannulation. Bifemoral cannulation consists of a venous
cannular in one femoral site, and the arterial cannula in the opposing femoral site. A singular
femoral site has the venous and arterial cannula in one femoral site. Central cannulation requires
surgical placement and is most used in the open-heart surgical patient population. In central
cannulation, the drainage cannula is in the right atrium, and the return cannula is placed directly
in the aortic arch (ELSO, 2020).
VV ECMO provides support to the lungs only. In this ECMO population, the patient’s
heart must be functioning adequately to meet their oxygenation needs. The drainage cannula is
place in a large vein, and the return cannula delivers oxygen-rich blood back into a large vein.
This patient population has three methods for cannulation: North-South cannulation, bifemoral
sites, a singular femoral site, and dual lumen cannulation. North-South cannulation consists of a
single cannula in the right internal jugular vein, and a single cannula in either the right or left
femoral vein. Dual lumen cannulas have both a drainage and return cannula forming a single
cannula and are placed in the patient’s right internal jugular vein (ELSO, 2020).
Peripheral cannulation is defined as either VA or VV ECMO cannulation that is placed in
the femoral or internal jugular sites. Central cannulation refers to VA ECMO that requires a
sternotomy for placement. Central cannulas need a specific dressing that is applied in the
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operating room. Dual lumen cannulas include both arterial and venous flow in a singular
cannula with two lumens. These cannulas are not frequently used at the facility of interest. This
project will focus on peripherally cannulated patients without dual-lumen cannulas, and therefore
exclude all centrally cannulated patients and patients with dual lumen cannulas.

PICO Question
A clinical question was developed in the Population (P), Intervention (I), Comparison
(C), Outcome (O) (PICO) format. The clinical question to guide the literature review is as
follows: In adult patients receiving venous-venous (VV) or venous-arterial (VA) ECMO therapy
via bifemoral or single-lumen internal jugular with singular femoral (North-South) access points,
does the implementation of a cannula dressing bundle including sterile dressing procedures and
anchoring methods decrease the frequency of required dressing changes due to insertion site
bleeding and/or loss of dressing integrity?
The purpose of the proposed project aims to generate an evidence-based bundle for
ECMO cannula site care inspired by data related to CLABSI bundle implementation, types of
dressings utilized, and anchoring devices. The selection of supplies utilized for ECMO cannula
site care will be based on a thorough literature review to determine the best-suited supplies to
sterilely care for an ECMO cannula insertion site as well as methods to determine and monitor
dressing integrity and saturation of dressings. CRI will be a secondary outcome and measurable
through the presence, or absence, of CRIs within our respective patient population through the
duration of this project. CRI parameter suggestions are discussed below.

Project Term Definitions.
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In order to mitigate confusion, the National Healthcare Safety Network (2020) created by
the Center for Disease Control and Prevention (CDC) was referenced for the appropriate
terminology used to define the standard terms commonly utilized throughout the project and
listed below:
•

Central line-associated bloodstream infection (CLABSI): refers to a positive
bloodstream infection in a patient with only a central line and no ECMO cannulas.

•

Bloodstream infection (BSI): refers to a positive infection in the bloodstream that
is not secondary to any other body site. For the purpose of this paper, BSI will
describe a positive blood culture that is unable to be linked to either the ECMO
cannula or the central line in a patient that is receiving ECMO therapy.

•

Cannula-related infection (CRI): refers to a positive BSI while a patient is on
ECMO.

•

Cannula site care bundle: may be used interchangeably with the "cannula care
bundle." This wording refers to the sterile dressing process for the ECMO
cannula insertion site, as well as the anchoring method for the cannula.

Differentiating CRI from CLABSI in the ECMO population is challenging because there
is not a known method for identifying whether a BSI was caused by an ECMO cannula or an
invasive line. There are currently no ELSO endorsed parameters or guidelines available to
distinguish if a central line or an ECMO cannula is the primary cause for a positive BSI during a
patient’s ECMO therapy. For this reason, the CDC currently does not track bloodstream
infections that occur while a patient is on ECMO due to the challenges of differentiating a CRI
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from a CLABSI. Proposed parameters for defining a CRI are discussed further in the literature
review.

Evidence

Literature Search Strategy
Search Method.
A literature search was completed by utilizing the research databases PubMed, CINAHL,
ProQuest, and the review database Cochrane Library by using the search parameters listed in
Appendix B. An internet search performed using Google provided direction to the CDC website
where the clinical practice guideline for CLABSI were located. Other valuable research
documents were discovered from trials conducted by the CDC and their corresponding articles
related to the CDC’s research. From these searches, articles were chosen based on their relevance
to the chosen key terms and combed through for the quality of evidence, study design, sample
size, study setting, and patient population.

Selection Criteria.
The literature search was separated into two separate themes: ECMO cannula infections
and CLABSI rates. The search parameters for CLABSI rates and ECMO articles were focused
on the adult intensive care unit (ICU) patient population published between 2010 to 2020 and
published in the English language or translated to English. After the initial database search, the
review was expanded to include the differences in CLABSI rates when using chlorhexidine
gluconate (CHG), or medication-impregnated dressings or discs. By expanding the search with
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these terms, any non-suture securement devices were included to determine the difference
between the various items commonly utilized for central line securement and CLABSI
prevention. Lastly, studies on CLABSI-bundles were included, as well as differences in infection
rates related to different insertion sites for central venous catheters.
ECMO articles included in the literature review were those that discussed CRI and either
identified ECMO patient risk factors for CRI, discussed dressing and cannula site care methods,
and/or defined parameters used to define CRI. Studies that surveyed cannula site care
experiences at facilities providing ECMO therapies were also included. ECMO surveys
conducted for research purposes investigated data regarding ECMO cannula site care, dressing
practices, anchoring practices, and/or hospital protocols to guide the bedside provider’s dressing
strategies.

Included Studies.
For the final literature review, 19 articles were included based on research over the topics
of ECMO cannula securement, ECMO CRI, CLABSI rates related to central line location, and
CLABSI rates. These articles were analyzed to determine their relation to central line
securement, and CLABSI bundle procedures and how the interventions lowered rates of
CLABSIs post-implementation compared to pre-implementation. Inclusion criteria consisted of
confirmation of the study's intervention based on a statistical significance, relevance on the
subject matter related to the proposed Doctor of Nursing Practice (DNP) project, and quality of
evidence related to the type of study that would be accepted for due diligence the literature
review. Studies with data that were not statistically significant were included in the literature
review as these studies were of clinical significance and provided pertinent data on ineffective
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methods for site care, allowing for the project to be adjusted as appropriate. A comprehensive
table of included and excluded studies is available in Appendix A.

Description of Studies.
For the studies included in the literature review, eleven articles involved patients on
ECMO. To further break down the research, the subject matter of four studies are related to
securement methods used to safely prevent dislodgement of micro-shifts of the ECMO cannula
(Bull, Corley, Lye, Spooner, & Fraser, 2019; Bull, Corley, Smyth, McMillan, Dunster, & Fraser,
2018; Spencer, 2018; Tignanelli Weinberg, & Napolitano, 2019) and seven articles are directly
related to infection risk, prevalence, and BSI prevention in ECMO patients (Allou et al., 2019;
Aubron et al., 2013; Biffi et al., 2017; Corley et al., 2019; Hahne et al., 2015; Silvetti et al.,
2019; Vogel, Lew, Kao, & Lally, 2011). Of the articles related to central venous catheters
(CVC), five articles addressed research on CLABSIs, specifically. One article compared the
difference in rates of infection for specific insertion sites (Marik, Flemmer, & Harrison, 2012),
two articles focused on using antimicrobial dressings, aseptic dressing methods, and products for
CLABSI prevention (Webster et al., 2017; Yu et al., 2019), two articles focused on comparing
processes used to simplify regular CVC dressing changes (CLABSI bundles) and the effects
these various processes have on CLABSI rates (Grigonis et al., 2016; Wichmann et al., 2018).
Three additional articles were found outlining research that surrounds the safe securement of
CVCs (Mitchell et al., 2019; Ullman et al., 2015) and one article investigated the relationship
between proper securement of CVCs and CLABSI rates (Timsit et al., 2012).
By adhering to the guidelines for inclusion, the goal was to strive to focus on articles that
fulfilled the prerequired level of evidence determined by Melnyk and Fineout-Overholt’s
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Evidence-Based Practice in Nursing and Healthcare (2019). By thoroughly examining all articles
for validity, reliability, and applicability to the patient population, sixteen of the twenty-one
articles referenced come from qualitative studies within levels I-IV, and four studies referenced
include qualitative articles within levels V-VII. A summary of each article can be found in the
literature review table in Appendix C.
Figure 1
Levels of Evidence
Level of Evidence of Research Study
I – Systematic Review/
Meta-analysis of Randomized Controlled Trials
II – Single Randomized Controlled Trials
III – Quasi-Experimental Studies/
Nonrandomized Controlled Trials

IV – Cohort or Case-Controlled Studies

V – Systematic Review/
Meta-analysis of Qualitative Studies
VI – Single Qualitative or Descriptive Studies/
Evidence Implementation and Quality
Improvement Projects
VII – Expert Opinion

# of
Research Studies
Studies
2

Marik et al., 2012;
Ullman et al., 2019

4

Mitchell et al., 2019;
Timsit et al., 2012;
Webster et al., 2017;
Yu et al., 2019

2

Bull et al., 2018;
Hahne et al., 2015;

9

Allou et al., 2019;
Aubron et al., 2013;
Corley et al., 2019;
Glater-Welt et al., 2016;
Grigonis et al., 2016:
Schmidt et al., 2012;
Silvetti et al., 2019;
Vogel et al., 2011;
Wichmann et al., 2018;

1

Biffi et al., 2017;

1

Bull et al., 2019;

2

Spencer, 2018;
Tignanelli et al., 2019
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Population and Setting.
The sample population within the articles of our literature table is isolated to the adult
inpatient population. The setting for the articles referenced is predominately within the intensive
care unit, apart from the article by Grigonis et al. which was conducted within a long-term acute
care hospital setting.

Excluded Studies
Seven articles were reviewed and excluded from the literature review. Although the
articles contained data related to the search criteria provided above, these seven articles failed to
provide specific interventions to ECMO cannula site care, or the CLABSI intervention being
reviewed was not translatable to the ECMO cannula site. Therefore, these seven articles were
not considered in the final literature review process.

Review of Evidence

CLABSI Prevention
The articles by Mitchell et al. (2019), Ullman et al. (2015), and Webster et al. (2017)
indicate that the type of dressing utilized, Chlorhexidine gluconate (CHG) or silver-impregnated
dressing, both reduced rates of CLABSI by having a CHG, or silver-impregnated disc present
under the transparent dressing. According to the meta-analysis of randomized-controlled trials
conducted by Ullman et al., the rate of infection reduced from 30 infections per 1000 catheter
days to 19 infections per 1000 (RR 0.65, 95% CI 0.40-1.05) infection days when a CHGimpregnated dressing was used to cover a CVC versus a standard polyurethane (SPU) dressing.
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Also, in the same study, CLABSIs were reduced from 28 infections per 1000 catheter days to 17
(RR 0.60, 95% CI 0.39-0.93) infections per 1000 catheter days when a silver-impregnated
dressing is utilized, versus an SPU dressing to cover a CVC. (2015, pp.5-6)
Timsit et al. (2012) found that an increased frequency of dressing disruptions was directly
related to an increased risk of microbial colonization beneath the CVC dressing. Researchers
tested two patient groups with CVCs to determine the likelihood of microbial colonization by
allocating one patient group to a scheduled 3-day dressing change cohort and the next patient
group to a 7-day cohort, respectively. It was established that multiple statistically significant
variables existed that explained the disruption of CVC dressings. For example, patients being in
a comatose state, an increased Sequential Organ Failure Assessment (SOFA) score, which
indicates a higher level of organ failure, and an increased Simplified Acute Physiology Score II
(SAPS II) which is an estimator of mortality in patients all impact the integrity of CVC dressings
in the ICU setting. The researchers concluded that each dressing removal increased the risk for
events such as, catheter colonization from the first dressing removal (p= 0.16, HR= 1.30, 95% CI
0.90-1.87) compared to the final dressing removal (p <0.0001, HR=13.99, 95% CI 9.88-19.82),
CLABSI first dressing removal (p= 0.17, HR=2.65, 95% CI 0.67-10.56) compared to the final
dressing removal (p <0.0001, HR=18.11, 95% CI 5.66-57.88), and other major catheter-related
infections from the first dressing removal (p= 0.33, HR=1.94, 95% CI 0.50-7.48) compared to
the final dressing removal (p <0.0001, HR=12.51, 95% CI 3.95-39.62). The researchers
calculated that all three microbial categories (catheter colonization, CLABSI, and other major
catheter-related infections) increased the calculated hazard ratio for each category with each
dressing removal. The articles by Grigonis et al. (2016) and Wichman et al. (2018) address the
efficacy of dressing bundles towards decreasing the rates of CLABSIs within their respective
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patient populations. Wichman et al. examined the addition of a checklist to the existing CLABSI
bundle to increase adherence and effectiveness to the bundled steps (2018). The researchers’
believed that, by creating a bundle checklist, they would create an additional tool to improve the
effectiveness of the preexisting bundles and further reduce the frequency of CLABSIs within the
ICU patient population. The rate of CLABSI infection in the pre-experimental observational
group was 5.9 infections per 1000 catheter days and reduced to 3.8 infections per 1000 catheter
days with the addition of the CLABSI checklist (Wichman et al., 2018, p.3). The article by
Grigonis et al. (2016) addresses the decrease in CLABSI infections when establishing a bundle
program in a long-term acute care hospital (LTACH). The group evaluated the rates of CLABSI
infection 14-months pre-bundle and 14-months post-bundle initiation. The CLABSI-bundle that
the researchers implemented at an LTACH included education on the CLABSI-bundle protocol
to all staff members responsible for using CVCs, the mandatory use of alcohol-based central
catheter caps, CHG dressings, and the formation of a CVC-nursing team to maintain all CVCs
and demonstrate annual competency. The implementation of a CLABSI bundled program
decreased the rate of CLABSI standardized infection ratio (SIR) as defined by the CDC from
1.28 infections per 1000 catheter days to 0.96 infections per 1000 catheter-days (2016, p. 169).

CLABSI Clinical practice guidelines.
The CDC developed a guideline to prevent intravascular catheter-related infections in
2011 and updated recommendations in 2017. The CLABSI clinical practice guideline
recommends the following for central line catheter care (CDC, 2017):
•

Sterile gauze, transparent, or semi-permeable dressings should cover the catheter site.
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Sterile gauze is recommended if the patient is diaphoretic or the insertion site is oozing,
followed by an alternative dressing once the oozing or sweating is resolved.

•

Antibiotic creams and ointments are not recommended.

•

If a non-occlusive dressing or hemostatic dressing is used, the dressing should be
changed every two days.

•

The occlusive dressing should be changed every seven days unless the patient is at high
risk for catheter dislodgement or the dressing becomes compromised before the change
date

•

Chlorhexidine-impregnated dressings or discs are recommended for patients aged 18
years and older. All dressings need to be cleared by the Food and Drug Administration
(FDA) and have a specific clinical indication to reduce CLABSI.

•

Daily 2% chlorhexidine skin cleansing of the full body is recommended for all patients
with central venous catheters.

•

Sutureless securement devices are recommended.
Utilizing the Appraisal of Guidelines for Research and Evaluation (AGREE II)

instrument, this specific clinical practice guideline was found to be of high quality.
The CDC’s central line guideline (2017) was reviewed and rated by the both authors
using the AGREE II tool (2013). When analyzing the results organized in Appendix D, it is
evident that this guideline meets the AGREE II high standards with an overall percentage of
88.4%. Both reviewers recommend the clinical practice guideline, but with modifications due to
the continually evolving nature of CLABSI guidelines since the current guideline was last
updated in 2017. Please refer to Appendix E for a detailed AGREE II scoresheet.
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ECMO cannulation sites represented
Peripherally cannulated VA and VV ECMO were well represented throughout the
literature reviewed in 10 out of the 11 of the ECMO-related content. Centrally cannulated VA
ECMO was also well represented within the literature, but this is viewed as a surgical
intervention requiring a cardiothoracic surgeon. Due to the unique dressing and antibiotic
requirements of this population, data related to centrally cannulated ECMO patients was not
considered to be in the scope of the proposed project. Articles related to central cannulation data
were reviewed if the researchers were simultaneously investigating peripheral cannulation.

Cannula-related infection
The rate of BSIs in patients on ECMO ranged from 16 to 24.7 BSI days per 1,000 ECMO
days (Allou et al., 2019; Aubron et al., 2013; Biffi et al., 2017; Silvetti et al., 2019; Schmidt et
al., 2012). According to the CDC's 2018 Hospital Acquired Infections Progress Report (2019),
the calculated CLABSI infections for the State of Minnesota calculates to 0.8664 CLABSIs per
1000 catheter days and Nationally as 0.9499 CLABSIs per 1000 catheter days. There is a
significantly higher incidence of BSI in the ECMO population compared to national rates for
CLABSI, highlighting a need for practice change, further investigation of risk factors associated
with CRI, and national CRI monitoring parameters.
Hahne et al. (2015) sought to clarify criteria for CRI by culturing the end of the ECMO
cannula immediately after decannulation. The researchers found that 15.9% of the cannulas
cultured in the study were positive for colonization. Commonly colonized organisms identified
by ELSO include Coagulase-negative staphylococci, Candida species, and pseudomonas (ELSO
Infectious Disease Task Force, 2019). The sole statistically significant risk factor for positive
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CRI identified by Hahne et al. (2015) was positive blood culture during the ECMO run (p =
0.010). The patients who had positive blood cultures during ECMO therapy were at 4.762-time
higher odds for the development of positive cannula colonization, indicating a positive CRI.
Although the sample size for this article of 96 patients was rather small, this is the only article
known to the writers in which the cannula tip underwent microbial analysis to determine if the
ECMO cannulas were the cause for the BSI. The challenge of this method for determining CRI,
is the ECMO therapy must be discontinued to obtain a culture on the ECMO cannula tip, which
may endanger the patient’s life.
Five articles sought to define CRI by creating a timeline post-cannulation (initiation of
ECMO) and post-decannulation (discontinuation of ECMO) in which a positive BSI would be
attributed to the ECMO cannulas (Allou et al., 2019; Aubron et al., 2013; Corley et al., 2019;
Schmidt et al., 2012; Silvetti et al., 2019). Three of these five articles defined a positive CRI as a
BSI that occurred 48 hours after the patient was initiated on ECMO (Allou et al., 2019; Aubron
et al., 2013; Silvetti et al., 2019). Two articles defined the ECMO insertion site as a surgical site.
The studies by Allou et al., (2019) and Corley et al., (2019) both determined all patients that
were on ECMO support that had a positive blood culture for up to 30 days after decannulation
met parameters for CRI. Silvetti et al. (2019) included post-cardiotomy patients on ECMO with
positive BSI for 48-hours after decannulation, while Aubron et al. (2013) included ECMO
patients up to 72 hours post decannulation as positive for BSI. Schmidt et al. included all VA
ECMO patients (including post-cardiotomy) who had a positive BSI 24 hours post cannulation
and 48 hours post decannulation (2012).
The criteria for CRI by Aubron et al. (2013), was created by using the CLABSI
surveillance guidelines by the CDC from 2008. Two articles defined peripheral cannula sites as
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surgical sites and therefore utilized the CDC definition for a surgical site infection defined by the
CDC (Allou et al., 2019; Corley et al., 2019). CLABSI criteria were utilized for CRI criteria in
the Schmidt et al. article (2012); however, the year that the criteria originate is not specified.

Cannula anchoring
In vitro porcine skin samples were cannulated and secured using different methods for
sutureless cannula securement in the article by Bull et al. (2019). The study consisted of cohorts
with six individual 21 French cannulations in pigskin with an adhesive dressing at the insertion
site in addition to one of the following securement methods: Dermabond, Grip-Lok Universal
securement device, MultiFix Unifix universal tube and catheter securement, and Tensoplast
elastic adhesive bandage. It was found that Dermabond required the highest amount of force to
dislodge the cannula (p < 0.0001). Unfortunately, to remove Dermabond acetone must be
applied. After applying acetone to the cannula, there was noted to be a significant degradation to
the tubing. The Grip-Lok and MultiFix required a significantly higher force for dislodgement
when compared to the Tensoplast tape (p < 0.01). This is the only study known that investigated
the effectiveness of specific anchoring devices with ECMO cannulas
An article by Tiganelli, Weinberg, & Napolitano (2019) provides an expert opinion on
securement methods for internal jugular (IJ) cannulas. This cannula location has proven to be
challenging to secure due to the proximity to the patient's face, providing no points for adequate
anchoring. The authors of this article shared their experiences using Coban to make a headband
around the patients' heads to prevent cannula migration, which proved problematic when the
adhesive's capability was lost. The opaque- nature of Coban causes difficulty in assessing the
skin beneath the wrap. Tignanelli et al. shared that their facility uses Hold-N-Place leg bands,
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which initially intended for Foley catheter securement. This method is preferred to the Coban
for IJ cannulas as it allows for better assessment of the skin, and patients seemed to find it more
comfortable (Tiganelli et al., 2019). The patients' comfort was not statistically analyzed, and this
information was based on the opinion of the writers' expert opinion.

ELSO surveys.
Bull, Corley, Lye, Spooner, & Fraser (2019) surveyed 396 ELSO registered ECMO
coordinators and directors investigating different methods for securing and dressing peripherally
inserted cannulas. Researchers received 391 individual responses from 45 different countries
(46% of respondents were from the United States), 76% of respondents reported having a written
guideline or policy for ECMO cannula dressing management, and 78% of respondents believed
"that an international evidence-based guideline for ECMO line management would be beneficial
to inform or improve bedside practices" (Bull et al., 2019, p. 7). Cannula dislodgement,
migration, and accidental decannulation in the last five years have been reported to have
occurred at 34% of the responding facilities. The respondents indicated what was believed to be
the cause of the critical event, and inadequate cannula securement methods were sited to be the
primary cause accounting for 28% of reported dislodgement events (Bull et al., 2019).
Interestingly, Bulle et al. shared that other causes for reported cannula dislodgements
occurred when a patient removed a cannula (12%), during turning or bathing of a patient (11%),
and transport of a patient (4.2%). These events could all arguably be related to inadequate
securement techniques. The specific cause for cannula dislodgment was not specified in 25% of
the reported events (Bull et al., 2019). There is a concern of under-reporting of this adverse
event as providing detail was an optional response in the survey.
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A survey of members of the ELSO registry regarding ECMO insertion and maintenance
of cannulas, antibacterial prophylaxis, and infection surveillance was conducted by Glater-Welt,
Schneider, Zinger, Rosen, & Sweberg (2016). This survey was sent to ECMO directors and
coordinators at 152 facilities based in the United States, 85 institutions participated. A
standardized facility-based approach to cannula dressings was reported by 82.9% of the surveyed
facilities. Semi-permeable transparent dressings were used in 57.3% of respondents. Glater-Welt
et al. highlight a large variability in infection prevention practices and state that there is a need to
standardize the bedside approach to cannula care (2016).
A third ELSO survey by Vogel, Lew, Kao, & Lally analyzed potentially modifiable risk
factors for infectious complications during ECMO support utilizing the ELSO registry data from
1987 to 2009, including 2,996 adult ECMO runs as well as data on pediatric ECMO runs. An
infectious complication was loosely defined without clear rationale as the presence of a new
organism while on ECMO or a white blood cell count below 1500. Risk factors for infectious
complications were found to be ECMO therapy lasting > 10 days (OR= 1.09, p < 0.001), the
adult population (O 2.24, p < 0.001), and positive blood culture prior to the initiation of ECMO
(OR= 2.49, p < 0.001).

ECMO community outreach.
The project leaders have become registered members of ELSO since the preliminary
stages of the DNP project. Using the ELSO directory for ECMO coordinators in the United
States, the DNP students drafted an e-mail to informally survey dressing practices at various
ECMO centers. Of the 14 randomly selected ECMO coordinators contacted, 5 ECMO
coordinators responded, offering information on practices at their centers. Variance in ECMO
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cannula site care practices was found across the responses received with a summation of the
practices being:
•

Utilization of sutures for ECMO cannula stabilization is the most common
practice across the polled ECMO centers.

•

A CHG-based scrub was used to cleanse the skin consistently on all patients.

•

The BioPatch brand of CHG-impregnated disc was utilized for CRI-prevention
for those sites that used CHG-impregnated discs.

•

ECMO site dressing changes were not consistently changed at regular intervals

•

ECMO site dressing was consistently changed if bloody.

•

No ECMO center indicated having any ECMO dressing change protocol to
standardize their practice.

Cochrane reviews.
A critical appraisal of a systematic review for dressings and securement of central venous
catheters by Ullman et al. (2019) can be found in Appendix F. The systematic review looked at
21 different articles to compare available dressing and securement devices in order to identify the
best dressing regimen to prevent CLABSI. The population included short- and long-term CVCs,
consisting of both tunneled and non-tunneled CVCs, internal port-a-caths, hemodialysis lines,
and peripherally inserted central catheters in patients of any age. The dressings reviewed
included standard polyurethane, chlorhexidine impregnated, silver nitrate impregnated, sterile
gauze, and the utilization of anchoring methods. In summary, the reviewers stated that “there
was inadequate research to permit us to make recommendations about CVC security using the
different dressing and securement products” (Ullman et al., p. 32, 2019). The large variety of
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marketed dressings is a weakness in this review; reviewers were unable to pinpoint one superior
dressing method. Despite this, the reviewers did consistently find a decrease in CLABSI rates at
facilities that utilizes chlorhexidine impregnated dressings and discs.
An appraisal of a systematic review of the risk of catheter-related bloodstream infections
(CRBIs) of femoral CVCs compared to the subclavian and internal jugular venous placement of
CVCs by Marik et al. (2012) can be found in Appendix G. The meta-analysis reviewed two
RCTs and eight cohort studies to evaluate for any increased prevalence of CRBI rate depending
on femoral venous placement over subclavian and internal jugular placement. The study
population was isolated to the adult patient population with non-tunneled CVCs and examined
the difference that anatomical placement may have on risk for infection for CVCs. The
researchers did not discuss what role the type and quality of external dressing played in the
infection rates of their CVCs. In summary, the researchers evaluated that the data favored
placement in the internal jugular vein as the lowest risk for CRBI, when compared to femoral
placement (p= 0.005, RR= 1.90, 95% CI 1.21-2.97) but concluded that there was no higher risk
for infection for femoral-placed CVCs when compared to a subclavian CVC (p=0.2, RR= 1.35,
95% CI 0.84-2.19). (Marik et al., 2012, 2482-2483)

Evaluation of Evidence
The literature reviewed does not provide clear clinical practice guidelines for best suited
sterile dressing and anchoring methods for ECMO cannulas. However, knowledge and clinical
practice guidelines aimed for central line dressings can be used to concoct a practical bundle
approach for ECMO cannula insertion site care (ELSO Infections Disease Taskforce, 2019).

ECMO CANNULA CARE BUNDLE

24

The literature reviewed suggests that there is a decrease in CLABSI rates when variables
such as dressing change bundles, decreased frequency of dressing removal, use of CHGimpregnated transparent dressings, or CHG-impregnated discs, and checklists are used for CVCs.
At present, ELSO recommends the implementation of CLABSI bundles for bedside cannula care.
Regarding CRIs, research defines a CRI as a positive blood culture during ECMO therapy;
however, there is variability in the window of time around ECMO therapy in which a positive
blood culture would be considered related to the ECMO cannulas.
There are several gaps in the evidence discovered and, at this time, the articles reviewed
exposed that there is not a clear consensus for monitoring CRI. The CRI window has been
identified as 24-48 hours post-initiation of ECMO to 24 hours to 30 days after decannulation.
This variation in the defined time window is due to some studies identifying ECMO cannulas as
a surgical site, and others as an invasive device (Allou et al., 2019; Aubron et al., 2013; Corley et
al., 2019; Schmidt et al., 2012; Silvetti et al., 2019). The ELSO Infectious Disease Task Force
does not define CRI.
It is suspected that due to the lack of clear CRI criteria, there are currently no studies that
analyze the success of implementing a cannula care bundle to the ECMO population. The
project leaders are heavily relying upon successful CLABSI reduction methods to apply to the
ECMO cannula and patient population. Heterogeneity for a care bundle of a central line
compared to an ECMO cannula cannot be guaranteed. However, it is the current
recommendation from the ELSO Infectious Disease Task Force to utilize this approach (2019).

Theoretical Basis
Synergy Model for Patient Care
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The Synergy Model for Patient Care is a middle-range theory that was developed by the
board of nurses from the American Association of Critical-Care Nurses (AACN) in the mid1990s. The purpose of the Synergy Model is to articulate nursing contributions, activities, and
outcomes regarding care for critically ill patients. The original concept was designed to create a
comprehensive exam that not only focused on the skill required for critical care nursing but also
focused on holistic care of the patient and analyzes critical thinking skills. This exam is the
Critical Care Registered Nurse (CCRN) exam (McEwen & Ellis, 2019). The conceptual
framework of this model enhances nursing practice. It works to improve patient outcomes to
adapt to the needs of the complex patient by identifying patient and nursing-specific strengths
and weaknesses (Hardin & Kaplow, 2017).
The Synergy Model combines outcomes derived by the patient, the nurse, and the
healthcare system by producing a joint effect between eight key nursing competencies and eight
identified patient characteristics. The eight nurse competencies include the following: clinical
judgment, clinical inquiry, facilitation of learning, collaboration, systems thinking, advocacy and
moral agency, caring practices, and response to diversity (McEwen & Wills, 2019). These nurse
competencies reflect an integration of knowledge, beliefs, skills, and attitude that are needed to
optimize care for patients, improve patient outcomes, and reflect a level of skill that is required
to care for critically ill patients (Hardin & Kaplow, 2017). The eight patient characteristics
described in the Synergy Model include the following: resiliency, vulnerability, stability,
complexity, resource availability, participation in care, participation in decision making, and
predictability. These patient characteristics consider the physical, social, psychological, and
spiritual aspects of the patients shift the focus to holistic care and fosters a healing environment
(Hardin & Kaplow, 2017).
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The patient's needs to drive the nursing competencies that are needed for the care of the
patient (Hardin & Kaplow, 2017). In congruence with the cannula care bundle implementation,
the patient’s complexity will require nursing clinical inquiry and systems thinking. The
physiological complexity of the ECMO patient requires diligent care from the bedside nurse and
the ECMO nurse specialist. Project leaders will depend on the clinical inquiry of the bedside
providers to adjust dressing practices based on expert opinion as needed, as there are limited
supplies available that are intended for cannula dressings. Systems thinking refers to the “body
of knowledge and tools that empower the nurse to manage environmental and system resources
for the patient” (Hardin & Kaplow, p.105, 2017). Project leaders will need the systems thinking
of leadership in the cardiovascular ICU (CVICU) to obtain appropriate supplies and successfully
implement the project.

APPLICATION OF THE EVIDENCE

Problem Identification.
At a large medical institution in the Midwestern United States, the 32-bed CVICU cares
for an average of 100 venovenous (VV) and venoarterial (VA) ECMO patients per year (Allina
Health, 2019). Please refer to Figure 1 for a reference to the institution specific ECMO program
growth. The institution’s current policy for ECMO cannula site care and dressings is to utilize
the current CLABSI bundle protocol for dressing the cannulas sterilely, as recommended by
ELSO. However, often the size of the dressing, the chlorhexidine gluconate-impregnated
antimicrobial disc, and other supplies are inadequate to dress the cannula appropriately. Nurses
are forced to implement inconsistent and individualized strategies to appropriately cover the
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ECMO cannula insertion site and maintain sterility, resulting in a lack of continuity in practice
and difficulty replicating effective strategies.
All ECMO specialists and bedside nurses trained to care for ECMO patients were
informally surveyed as part of the unit’s quality improvement practice initiative on current
dressing practices for the ECMO cannula insertion site. Of the responding nurses, 70% use their
own combination of materials to sterilely provide site care for the insertion site, since there are
no designated supplies or protocols specific to ECMO cannula site care. The remaining 30%
solely used a central line site care kit. The most common reasons for changing the cannula site
dressing followed by the percent of responders selecting the rationale were the following:
bloody/saturated dressings (97%), dressing no longer intact (89%), dressing was removed for a
procedure (51%), or the dressing was due to be changed (51%).
Of the respondents, only 32% of nurses believed that the central line dressing kit
provided adequate supplies for ECMO cannula site dressing changes. The remaining nurses
stated that the central line dressing kits provided dressings and BioPatches that were too small,
the site cleaning supplies were inadequate, and there was an insufficient amount of skin
protectant provided (Cavilon barrier). About 10 responders indicated in the free text or comment
sections that the addition of a 10”x4” Tegaderm in commonly used when the central line
Tegaderm is not adequate to provide occlusive coverage over the insertion site.
Nearly 70% of the responding nurses indicated that they felt the current cannula anchor
practices either were sometimes or never provided adequate prevention of movement and
migration of the ECMO cannulas. The methods for cannula securement indicated by the
surveyed nurses included either a combination or singular use of the following methods: suturing
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to the skin (88.9%) or a Stat-lok or Hollister tube attachment device seen in Figure 2 (86%),
taping to the skin (15%).
Based on nursing response, there is a need for generating a kit that is specific to the
peripheral ECMO cannula site. The nursing staff have expressed that there are multiple different
methods for providing site care to an ECMO cannula site, resulting in a discontinuity in practice.
Furthermore, the inadequate sizing of the products that are used results in nursing staff using
additional resource to create an occlusive barrier around the insertion site. Investigating better
suited supplies for ECMO cannula sites will not only allow for a consistent care method, but
eliminate the use of extra Tegaderms, chlorhexidine swabs, extra BioPatches, anchoring device,
and barrier swabs that are used for these sites. A secondary outcome of the bundled approach to
dressing the ECMO cannula insertion site is a simplified charging process in which all the
materials used will be clustered in one charge as opposed to each materially individually.

Figure 2.
To the left is the Maquet StatLok tube securement. To the right is the Hollister vertical tube
securement.
Utility and feasibility.
The cannula site care bundle is a clinically feasible evidence-based intervention. There
are two major benefits of the Cannula Site Care Bundle which would include a unified approach
to ECMO cannulation site care, and potentially a decreased risk for CRI. By providing a unified
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approach, this will allow for all nursing staff to follow a designated flow as to how the site care
should be completed. A potential risk of this project is that the CLABSI data investigated is not
translatable to the ECMO cannula site and using a CLABSI approach and products that are not
specifically designed for the ECMO cannula site could increase infection risk. The risk to the
patient is the same in the project implementation phase as it is with current ECMO cannula site
care practices; therefore, this project would not impose an increased risk.
The DNP students presented the proposed project to key stakeholders of the project. The
cannula site care bundle was approved by the ECMO nurse specialist group on October 14, 2020,
and the Cardiovascular ICU Breakthrough committee (CV Breakthrough) on October 13, 2020.
CV Breakthrough consists of representation from each of the following teams that primarily
provide patient care on the unit: cardiology service, heart failure service, hospitalist service,
intensivist service, cardiovascular surgery service, vascular surgery service, infectious disease
service, CVICU nursing management, the CVICU clinical nurse specialist, the patient care
director, respiratory therapy, pharmacy, infection prevention, and CVICU bedside nursing staff.

Recommendations based on literature.
The literature reviewed suggests that there is a decrease in CLABSI rates when variables
such as dressing change bundles, decreased frequency of dressing removal, the use of
chlorhexidine gluconate (CHG) impregnated transparent dressings or CHG-impregnated discs,
and checklists are used for central venous catheters (CVCs). ELSO recommends the
implementation of CLABSI bundles for bedside cannula care. The research defines a CRI as a
positive blood culture during ECMO therapy, although there currently is not a process for
monitoring or tracking CRI.
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The proposed ECMO cannula site bundle kit will consist of the following items:
•

1 – central line dressing kit, which includes:
o Clean gloves
o Sterile gloves
o Hand sanitizer
o Mask
o 1 – cavilon barrier (medium)
o 1 – Prevantics swabstick
o 1 – sterile drape
o 1 – 4” x 4” gauze

•

1 - 4” x 6” chlorhexidine impregnated dressing

•

1 – Cavilon barrier swab (small)

•

1 – Bioderm anchor

•

1 – additional Pevantics swabstick

The ECMO Cannula Site Care Bundle consist of a kit including a central line dressing kit
and the additional supplies. The following supplies from the central line dressing kit will not be
used and will be refunded to the patient’s individualized charges using the PAR system: 3 line
caps, large Tegaderm, BioPatch. Once the nurse has completed dressing the cannula insertion
site, the unused supplies will be returned to the baggy with the completed checklist. The DNP
students will then go back to refund PAR charges for the unused and unopened supplies. This
method has been selected by the project leaders because the specific ECMO Cannula Site Care
kits cannot be constructed in time for the implementation phase of this project. The central line
dressing kit consists of many of the supplies that are needed for project implementation, and
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therefore was the best option to implement the project within the determined timeline. Creating
the ECMO cannula site care kit is essential as it encourages the nurse to follow the evidencebased steps for cannula insertion site care and places the necessary materials in one spot to
simplify the process for gathering supplies.
There are two primary supplies that will be different from the central line kit for this
project: The CHG impregnated dressing and the cannula anchor. The CHG-impregnated dressing
is a more appropriate dressing for the ECMO cannula site because it is larger than the current
central line dressing (4” x 6.125” compared to 4” x 4.75”). Furthermore, there is currently no
CHG-impregnated disc that is large enough to make contact around the entire circumference of
the cannula at the insertion site as recommended by manufacturers for infection prevention. A
CHG impregnated dressing will provide better contact to the insertion site than a CHG
impregnated disk.
Current anchoring practices include the Maquet StatLock and the Hollister verticle tube
anchor (Figure 2). These stabilization devices prevent the cannula from lifting off the skin, but
do not prevent migration in and out of the insertion site. The only known study investigating
best cannula anchoring methods was done by Bull et al (2019). The two best anchors determined
in this study were the Grip-Lok and MultiFix adhesive anchors, as these two anchors required the
highest amount of force to dislodge a cannula in non-human subjects. Both dressing adhere to
both the cannula and the patient’s skin. When discussed with the stakeholders at the institution,
the adhesion to the cannula was deemed to be undesirable because it could delay emergency
needs in the event that the cannula would need to be manipulated by a provider. Furthermore,
the adhesive could leave residue on the cannula causing concern of someone inadvertently using
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adhesive removal directly on the cannula which could in turn cause breakdown due to active
ingredients in adhesive removal.
After product research and approval of CV Breakthrough and the ECMO nurse
specialist team, the Bioderm dual anchor was selected as a primary product for ECMO patients
(Figure 3). The benefit of this product is the adhesive is appropriate for patients with fragile
skin. Also, there are two non-adhesive anchoring points, the anchor accommodates items up to a
47 French (15.667 mm) diameter without risk of applying additional pressure on the cannula.
The ties are quick release to allow for prompt manipulation when necessary without risk of
residue on the cannula. The ties are also a rubbery substance that sticks to the cannula without
adhesives, which will reduce the risk of migration in and out of the insertion site when used in
conjunction with insertion site sutures.
Dressing changes will occur on all peripherally inserted ECMO cannulas every seven
days and as need when the dressing is soiled as recommended by current CLABSI guidelines. If
the site requires a hemostatic dressing, they will require changing within two days (CDC, 2017).
This is the current policy for central line dressings at the institution. A checklist has been created
and can be viewed in Appendix J to guide the nurses in the dressing change practice.
Figure 3.
Bioderm cathgrip securement device
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Plan for Implementation of EBP Change
The implementation of this project is planned to take place once the project and
Institutional Review Board approvals have been obtained. The goal timeline for implementation
would be by December 14, 2020. In order to have as large of sample size as possible and
complete the data analysis and dissertation of the DNP project by the end of May, the
implementation period will take place over a three-week period ending January 4, 2021.
Prior to the implementation phase, Institutional Review Board (IRB) approval will be
obtained, and the project leaders will train all 16 ECMO nurse specialists in the procedures and
documentation process related to the ECMO cannula site care kit. During this three-week
period, one of the project leaders will either be on site, or digitally available via Zoom during
shift change times to discuss any questions with the assigned ECMO specialist for the shift.
During these shift check ins, the project leaders will review any dressing changes that had
occurred, discuss documentation, and assess the availability of pre-made site care kits for future
dressing changes. Weekly email updates will be sent to the staff in the ECMO unit as well as an
initial email prior to the implementation phase. These emails will serve as reminders and updates
of this practice change.

Evidence-Based Practice Model
The Johns Hopkins Nursing Evidence-Based Practice Model (JHNEBP) was selected as
the evidence-based practice (EBP) model to best guide this project. The DNP students chose this
EBP model because of its emphasis on using the best evidence available to solidify the
foundations of nursing practice. This philosophy of practice is guided by translating research into
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application and teaches valuable lessons in autonomy and leadership by engaging in research
with interdisciplinary colleagues. The JHNEBP model can be viewed in Figure 4.
The JHNEBP process to develop nursing-led best practice implements a three-part
process for gathering evidence and disseminating this evidence into practice and is designed to
meet the needs of the practicing nurse researcher by offering a nursing-centered problem-solving
approach to clinical decision making. This research process within the practice model is referred
to as PET: Practice question, Evidence, and Translation and offers a cyclical approach to practice
and learning from research after discoveries are made.
The process begins with a general inquiry within nursing and transitions into the PETphase of the process, to which Appendix I offers greater detail regarding the PET-phase of the
JHNEBP model. After the translation phase of this model the evidence goes into a period of
appraisal where the evidence is scoured for quality, consistency, and applicability before any
publication and dissemination are conducted.
Figure 4
Johns Hopkins Nursing Evidence-Based Practice Model
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Participants and project setting.
The project will be implemented in the CVICU at a Twin Cities level III trauma center
and teaching hospital that offers peripherally cannulated VA and VV ECMO. All centrally
cannulated patients will be excluded from the project, as this population requires a unique
ECMO cannula dressing that is to be changed by the cardiac surgical staff per the facility’s
policy. All ECMO patients at this institution are cared for in its 32-bed CVICU, therefore
project implementation will occur on this unit.
Applications for the Internal Review Board (IRB) at both Abbott Northwestern Hospital
and Winona State University will be submitted with guidance from Sharon Wahl of Abbott
Northwestern Hospital and Dr. Kimberly Langer of Winona State University.

Readiness for change.
Facilitators of this project will be the clinical nurse specialist (CNS) for the
cardiovascular intensive care unit (CVICU) at the medical institution, Sharon Wahl, who is the
DNP Project mentor. Sharon will facilitate access to the institution’s ECMO data as well as
assist in forming key relationships with stakeholders of the project. The ECMO nurse specialists
and the ECMO educator will also prove to be a vital component to the project, as successful
implementation will depend on their participation in training to ensure adequate education on the
new cannula site care methods.
Barriers include a likely small sample size during the implementation phase due to the
rare nature of ECMO cannulation and the relatively short implementation timeframe. Despite
the high probability of a small sample size, there is a clear need for evidence surrounding
cannula site care; therefore, data will be analyzed regardless of the sample size obtained during
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the implementation phase. This potentiates the ability for future projects among other
institutions to branch off from this original research and allow for an eventual multi-center
implementation within the institution’s system.

Process for meeting supply needs.
The unit managers will assist the project leaders in special ordering the materials for the
Cannula Site Care Bundle. This budget has been approved by Mark Ebeling, the Cardiovascular
Emergencies Director, and it will be charged to the ECMO cost center per the approval of the
CVICU managers.
It is estimated that, for a 3-week implementation period, the project leaders will need to
generate roughly 20 kits. The project leaders have requested 50 CHG dressings and 30 Bioderm
Cathgrip anchors to be special ordered. This estimate is based on the roughly 100 ECMO
patients seen at this facility per year and guidelines for frequency of dressing changes. The
dressings will be changed once every seven days, and when visibly soiled to the point of a loss in
dressing integrity. The anchors will be less prone to soiling and will not require changing as
frequently as the CHG dressing since they will be located on the opposite shoulder for IJ
cannulation and outside the femoral cannula dressing for femoral cannulation. The project
leaders will monitor the stock of ECMO dressing kits every week and generate additional kits as
needed. One extra kit will be utilized for training purposes.

Training methods.
Eight of the 16 ECMO nurse specialists will be trained in the process for application of
the Cannula Site Care Bundle in the ECMO nurse education days occurring on December 3rd
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and 4th, 2020. The remaining eight ECMO nurse specialists will be trained at the monthly
ECMO specialist meeting that occurs on December 9th, 2020. Any nurses that are unable to
attend this meeting date, that still require training will be approached individually for training by
the DNP students. Training days have been approved by the unit’s nursing management, as well
as the ECMO nurse educator. This training will involve no additional hours beyond the nurse’s
individual work agreement, as training time will be incorporated in meetings that are already
planned. Training is estimated to take 30 minutes in a group setting, and 15 minutes
individually. The project leaders will be the sole educators providing the education for the site
care process to guarantee consistency in educational delivery with teach back to assess for an
appropriate level of understanding by the ECMO nurses and specialists.
The group of 16 ECMO nurse specialists will be responsible for all dressing changes on
the ECMO cannula site for patients in the CVICU for the duration of this project. This will be
most efficient to train this small specialized group during the pre-scheduled education days as
opposed to training all 72 bedside nurses that care for ECMO patient who does not have frequent
access to the simulation lab. The operating room technicians and the cardiac catheterization lab
technicians who place the initial dressing immediately after cannulation will also be excluded
from the cannula care bundle training. Cannulas frequently bleed for up to two hours postcannulation, requiring a dressing change once the patient arrives in the CVICU. For this reason,
the cardiac catheterization lab technicians will not require training at this time. A brief
presentation will be offered to the cardiac catheterization lab technicians and the operating room
technicians to provide education about the project with the understanding that the project may
eventually be implemented on these departments pending the outcomes of the project.

ECMO CANNULA CARE BUNDLE

38

Measurement methods.
Primary outcomes.
Data will be collected in the pre and post intervention cohort comparing the frequency of
required dressing changes and the rationale for changing the dressing. The DNP students expect
that by creating methodological approach specifically designed for ECMO cannula insertion site
care will yield less frequent dressing changes and lower incidence of saturated and/or no longer
intact cannula dressings. After the implementation period has has completed, the DNP students
will look at the number of dressing changes as well as rationale for changing the dressing in the
Cannula Site Care Bundle cohort will be collected and the data compared to pre implementation
data. Successful implementation would be indicated by a statistically significant decrease in the
number of dressing changes and/or the number of blood dressings in the “cannula site care
bundle” cohort.
The success of this project will also be determined by valued input from the 16 nursing
ECMO specialists. After the implementation phase is complete, all 16 ECMO nurse specialists
will be surveyed on their satisfaction with the new ECMO Cannula Site Care bundle and provide
context for feedback. The goal of this project is to provide the nursing staff with evidence-based
guidance to create a unified approach to caring for the ECMO cannula insertion site and improve
the workflow for the nursing staff by providing the bundled kit and to allow for streamlined
process of ECMO Cannula site care. This survey can be viewed in Appendix K.

Secondary outcomes.
The DNP students expect that by applying similar practices used in CLABSI bundles,
that incidences of cannula dislodgement and CRIs will be decreased in the post intervention
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cohort. These secondary outcomes will be challenging to measure in the expected small sample
population during the implementation phase of the project. For the purpose of this project, a
positive CRI will be defined as a positive blood culture that occurs in an ECMO patient 24 hours
after cannulation to 48 hours after decannulation. This timeframe has been agreed upon by
Sharon Wahl, CNS, and is the current timeframe for defining a CLABSI according to the CDC
(2017) and the institution’s policy. The insulting organism will also be recorded.

Project parameter definitions.
For further clarification, below are parameter definitions:
•

Pre-intervention cohort: All ECMO patients with peripherally inserted ECMO cannulas
from December 14, 2019 to January 4, 2020.

•

ECMO Cannula Site Care Bundle cohort or post intervention cohort: All ECMO patients
with peripherally inserted ECMO cannulas that underwent the Cannula Site Care Bundle
for dressing changes from December 14, 2020 to January 4, 2021.

•

CRI: A positive blood culture resulted on an ECMO patient 24 hours after cannulation to
48 hours after decannulation.
A list of confounding factors for comparison of the pre and post intervention cohorts was

generated by the project leaders and can be seen in Appendix L. The data will be appropriately
adjusted for age, race, admitting diagnosis, environment the cannulation occurred, and other
factors of interest. Once the baseline data is collected, a benchmark for the number of dressing
changes required and rank of most common reasons for dressing changes will provide a
benchmark for the intervention cohort. The pre-intervention cohort will consist of all
peripherally cannulated ECMO patient from December 14, 2019 to January 4, 2020.
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Data collection process.
The DNP students will conduct the pre-intervention and post-intervention data analysis
with the assistance of Sharon Wahl, CNS and the data analysts employed by the institution. A
statistician is available at the institution and will be contacted prior to beginning the data analysis
for consultation. Once the DNP students can meet with these key persons, and data collection
plan will be finalized.

Plan for data analysis.
Data analysis will be conducted by the DNP students using JMP Statistical Analysis
Software with consultation from the Statistical Department at Winona State University.

Resources, proposed budget, and timeline.
There will be no need for increased work hours for the staff implementing the project, as
training will take place during the quarterly ECMO nurse specialist education days and meeting
days. A cost analysis the ECMO cannula care bundle is available in Appendix H. Appendix H
offers a cost breakdown comparing current ECMO cannula dressing methods to the proposed
ECMO Cannula Site Care Bundle. The total cost for the supplies requested for the
implementation phase of this project is $596.79. This includes 50 CHG impregnated dressings
and 30 Bioderm Cathgrip anchors. No additional cost will be accrued with training the ECMO
nurse specialists as all training will occur within the nurses’ current work agreement.
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The budget for this project has been marked to be included in hospital site’s ECMO
program costs and included as part of the hospital’s ECMO budget. This budget has been
approved by Mark Ebeling, the Director of Cardiovascular Emergencies.

Summary plan for implementation.
In summary, the 16 ECMO nurse specialists will begin training during the ECMO nurse
education days in December. Any nurses that are not trained during that time will either be
approached individually or received training during the ECMO specialist meeting on December
9th. The implementation period is planned for December 14th 2020 to January 4th 2021. The
CHG impregnated dressing and the Bioderm Cathgrip anchor will be special ordered by the
CVICU nurse management near the end of October. All budgeting has been approved by the
Director of Cardiovascular Emergencies.
Conclusion
In conclusion, based on the lack of data and efficacy of ECMO cannula dressing bundles
the project coordinators make the argument that this project is both necessary as a means for
increasing cannula site stability, while also decreasing CRIs. By implementing and creating
research that works at creating a best practice model for increased ECMO cannula site stability,
the DNP students will attempt to fill this gap in knowledge that benefits many ECMO patients in
years to come. By embarking on this research, both Winona State University and the medical
institution have the opportunity at sharing credit in any new discoveries and achievements that
are made with the implementation of this project, while also continuing a relationship that strives
for the best outcomes in patient safety, research, and education. As students working within both
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organizations, we take pride in fostering these relationships and creating research that will be a
positive reflection of both institutions with the dissemination of this research.
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Appendix A

Compendium of Included and Excluded Literature
Included Rationale
Author
Title
or
(year)
Excluded Rationale
Allou et al., Cannula-related infection in patient supported by Included – useful data on contributing risk factors associated with
2019
peripheral ECMO: clinical and microbial
possible CRI
characteristics
Aubron et Infections acquired by adults who receive
Included – identifies risk factors for patients that have nosocomial
al., 2013
extracorporeal membrane oxygenation: risk factors infections during ECMO therapy
and outcomes
Biffi et al., Infections during extracorporeal membrane
Included – a thorough literature review of available data on
2017
oxygenation: epidemiology, risk factors,
nosocomial infections during ECMO therapy
pathogenesis and prevention
Bull et al., Extracorporeal membrane oxygenation lineIncluded – analyzes different dressing/securement methods and
2018
associated complications: in vitro testing of
measures the force required to dislodge a cannula.
cyanoacrylate tissue adhesive and securement
devices to prevent infection and dislodgment
Bull et al., Cannula and circuit management in peripheral
Included – compares different methods for cannula care amongst
2019
extracorporeal membrane oxygenation: an
ELSO registered facilities.
international survey of 45 countries.
Corley et Nosocomial infection prevalence in patient
Included – this study is not yet complete but has excellent
al., 2019
undergoing extracorporeal membrane oxygenation: information for possible outcome measurement strategies related
protocol for point of prevalence study across
to the project.
Australia and New Zealand
Grigonis et Use of a central catheter maintenance bundle in
Included – Assesses pre-implementation to post-implementation
al., 2016
long-term acute care hospitals.
CLABSIs rates in a single-center acute care hospital.
Hahne et al., Cannula-related infection in adult medical
Included – investigates possible risk factors associate with
2015
intensive care unit patients undergoing
cannula related infections.
extracorporeal life support and extracorporeal
membrane oxygenation
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Marik,
The risk of catheter-related bloodstream infection Included – Reviews the literature to determine the risk of
Flemmer, & with femoral venous catheter as compared to
catheter0related bloodstream infections related to non-tunneled
Harrison. subclavian and internal jugular venous catheters: A CVCs inserted at the femoral site as compared to subclavian and
2012
systematic review of the literature and metainternal jugular venous placement.
analysis.
Mitchell et Central venous access device securement and
Included – Tests the feasibility of an RCT comparing “standard”
al., 2019
dressing effectiveness: The CASCADE pilot
care with three dressing and securement products to prevent
randomized controlled trial in the adult intensive central venous access device failure and compares dressing and
care.
securement products on failure rates, microbial colonization, and
intervention costs.
Silvetti et Bloodstream infections during post-cardiotomy
Included – Identifies risk factors for BSI in the ECMO
al., 2019
extracorporeal membrane oxygenation: incidence, population, particularly post-cardiotomy patients who are usually
risk factors, and outcomes
placed on prophylactic antibiotics
Spencer,
Securing vascular access devices: Using the right Included – thoughtful discussion of different available products
2018
securement method can improve outcomes and
for CVC securement, may apply to cannulas
decrease cost.
Tignanelli et Optimal methods to secure extracorporeal
Included – an expert opinion on securement methods for RIJ
al., 2019
membrane oxygenation
cannulas, no other data available.
Timsit et al., Dressing disruption is a significant risk factor for Included – the article is a secondary analysis of dressing study
2012
catheter-related infections.
performed in ICUs across multiple sites.
Ullman et Dressings and securement devices for central
Included - Compares the available dressing and securement
al., 2015
venous catheters (CVC).
devices for CVCs in terms of BSIs, catheter colonization entry,
and exit-site infection, skin colonization, skin irritation, failed
catheter securement, dressing condition, and mortality.
Vogel et al., Defining risk for infectious complications on
Included – research for identified risk factors associated with CRI
2011
extracorporeal life support
Webster et Chlorhexidine gluconate or polyhexamethylene
Included – Investigates the feasibility and safety of comparing
al., 2017
biguanide disc dressing to reduce the incidence of two antimicrobial-impregnated discs to prevent CLABSI.
central-line-associated bloodstream infection: a
feasibility randomized controlled trial (the
CLABSI trial).
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Wichmann Efficacy of introducing a checklist to reduce
et al., 2018 central venous line-associated bloodstream
infections in the ICU caring for adult patients.
Yu et al., Chlorhexidine gluconate transparent dressing does
2019
not decrease central line-associated bloodstream
infection in critically ill patients: A randomized
controlled trial.
de Campos The use of polyurethane transparent film in
Pereira
indwelling central venous catheter.
Silveira et
al., 2010
Glater et al., Nosocomial bloodstream infection in patients
2016
receiving extracorporeal life support: variability in
prevention practices: a survey of the ELSO
members
Hitchcock Medical adhesive-related skin injuries associated
& Savine, with vascular access
2017
Kao et al., Antimicrobial prophylaxis and infection
2011
surveillance in extracorporeal membrane
oxygenation patients: a multi-institutional survey
of practice patterns
Masuda et Effects of prone positioning on cannula function
al., 2014
and impair oxygenation during extracorporeal
circulation
Scheithauer Reduction of central venous line-associated
et al., 2013 bloodstream infection rates by using a
chlorhexidine-containing dressing.
Wells et al., Safety and feasibility of early physical therapy for
2018
patients on extracorporeal membrane oxygenator

51
Included – Tests the inclusion of a procedural checklist to a
CLABSI bundle to enforce its efficacy and reduction of infection
rates.
Included – Assess the effects of two different dressing types on
CLABSI rates.
Excluded – Small sample population and lack of supporting
statistical analyses.
Excluded – offers a guideline for positive CRI

Excluded – discussed possible adhesive-related skin injury, but
did not provide any data or product associations with different
types of dressings
Excluded – the article is focused on microbial analysis and
antibiotic treatment, not infection prevention and monitoring
practices.
Excluded – did not discuss methods for securing cannulas or
dressing cannulas before proning patient
Excluded – Study was funded by 3M and had several limitations
in the study, namely limited to a single-center.
Excluded – did not discuss cannula securement needs with
increased patient mobility
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Appendix B
Search Parameters for Data Collection
# of Hits
Database/Source Used

Date of Search

Keyword Used
Listed Reviewed

Used

1/25/20

“ECMO” and “Dislodgement”

Pubmed

10

4

2

1/25/20

“Extracorporeal membrane oxygenation” and

Pubmed

101

8

1

106

9

1

“cannula” and “management”
1/29/20

“central venous catheters” and “securement” or CINAHL
“anchor”

1/29/20

“central venous catheters” and “securement”

Cochrane Library

7

1

1

2/1/20

“cannula-related” and “infection” and

Pubmed

7

3

2

Pubmed

39

4

2

“extracorporeal”
2/1/20

“extracorporeal” and “acquire infection” and
“risk factors
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2/1/20

"Catheter-related bloodstream infection"

Cochrane Library

18

2

1

2/1/20

"Catheter-related bloodstream infection" and

CINAHL

51

13

4

"central line-associated bloodstream infections" CINAHL

23

2

1

"chlorhexidine gluconate:
2/1/20

or “clabsi” and “ICU"
2/1/20

“clabsi bundle” and “ICU"

ProQuest

22

2

1

2/1/20

“clabsi” and “femoral vein”

ProQuest

105

18

3
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Appendix C
Literature Review Table

Reference

Purpose

Sample,
Setting

Design,
Framework

Variables, methods for
measurement

Findings

Allou, N., Pinto, Provide data to All adult
Observational,
Variables associated with 39 cases of CRI were
CRI were assessed by
diagnosed 9 days after
H., Perischini, R., create a better patients who retrospective
knowledge
of
underwent
cohort
study
comparing
CRI
patients
to
cannulation (17.7%)
Bouchet, B.,
cannula
related
ECMO
those
without
CRI
that
Braunberger, E.,
infections
cannulation at Cannulas were
underwent ECMO therapy. Incidence of CRI was
Lugagne, N.,
(CRI)
in
a
French
sterilely
removed
at
17.2/ 1,000 ECMO days
Belmonte, O.,
patients
university
the end of ECMO
Suspected CRI was defined 9.2/1,000 VV ECMO days
Martinet, O.,
supported by hospital 23- therapy. When a CRI at the facility in this study 23.6/1,000 VA ECMO
Delmas, B.,
ECMO in order bed intensive was suspected, the
as having one or all of the days.
Dangers, L., &
to improve
care unit
tips were sterilely cut following signs: local signs
Allyn, J. (2019). cannula
between
and send for
of infection at insertion site, significant variables for
Cannula-related
management. January 2010 microbial analysis
positive culture from either CRI risk were: renal
infection in patient
and
the site of infection via
replacement therapy
supported by
December
Cannula sites cleaned needle aspiration or surgical (p=0.022),
2016
with povidone
exploration or infection
# of blood transfusions
peripheral ECMO:
Sample size iodine-alcohol and occurring within 30 days
during ECMO support
clinical and
included 220 covered with
after ECMO insertion
(p=0.02)
microbial
adult patients occlusive dressing
(defined by CDC as a
ECMO median days
characteristics.
every
2
days.
surgical
site
infection)
(p=0.015).
American Society
Patients
that
Blood
cultures
were
only
for Artificial
had centrally Prophylactic
performed when an
Antibiotic therapy at time
Internal Organs
cannulated
antibiotics were not infection was suspected.
of ECMO cannulation was
65(2). Doi: .
ECMO or had routinely utilized
not associated with
https://doi.org/10.1
peripheral
unless patient
ICU length of stay, hospital reduced CRI (p=0.57)
097/MAT.0000000
ECMO for
underwent cardiac
length of stay, and in
000000771
less than 2
surgery. antibiotics hospital mortality was also Median LOS in ICU was
days were
were initiated once analyze when comparing
23 days in CRI group vs.
excluded
CRI was suspected. CRI to non-CRI ECMO
15 in non-CRI group (p <
patients
0.001)
151 VA
Median hospital LOS was
ECMO
40 days in CRI and 24 in
patients and
non-CRI (p = 0.002)
69 VV
ECMO
patients

Implications

Level of
Evidence

Although did discuss IV
standardized suturing
technique used at
facility, did not
discuss standardized
beside dressing and
anchoring practices.
Researchers in this
article state that it is
difficult to apply
CLABSI bundles to
ECMO dressing, but
methods such as
CHG bathing,
antimicrobial
dressings and other
methods to prevent
CLABSI need to be
investigated in
relation to ECMO
cannulas
Currently no
guidelines for CRI
monitoring, these
guidelines were
decided by expert
panel at facility
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Reference

Purpose

Aubron, C.,
Analyze
complications
Cheng, A. C.,
Pilcher, D., Leong, that occur in
patients on
T., Magrin, G.,
ECMO,
Cooper, D. J.,
Scheinkestle, C., & determine
associated risk
Pellegrino, V.
factors and the
(2013). Infections
consequences
acquired by adults on patient
who receive
outcomes.
extracorporeal
membrane
oxygenation: risk
factors and
outcome. Infection
Control and
Hospital
Epidemiology,
34(1), 24–30.
doi:10.1086/66843
9

Sample,
Setting
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Design, Framework Variables, methods for
measurement

Findings

Implications

Level of
Evidence

Alfred
Retrospective
Patients did not routinely
24 patients experienced a Researchers did not IV
Hospital in observational study – receive prophylactic
blood stream infection.
state what the
Victoria,
correlational cohort antibiotics.
Rate of bloodstream
infection prevention
South
study
infection (BSI) was 15.7 practices were for the
Australia. 45Most common cannulation cases per 1,000 ECMO
ECMO population on
bed ICU
Nosocomial BSI,
sites were bi-femoral with days.
cannula dressings,
specializing catheter-associated 8fr distal perfusion catheter
anchoring
in burns and urinary tract
used for arterial cannula
Statistically significant risk techniques, VAP
trauma
infections and
sites.
factors for blood stream bundles or CAUTI
hospital-acquired
infections on ECMO were prevention.
Sample
pneumonia were
Researchers also analyzed the following: Duration of
included
considered if they
the following factors:
ECMO days (p=0.0004),
patients
occur within 72 hours APACHE II, SOFA score, total units of RBC
receiving
after ECMO
Pao2:FiO2 ratio,
transfused (p=0.0092).
ECMO for > cessation or 48 hours hematological malignancy,
48 hours over after ECMO
occurrence of cardiac arrest, Hospital LOS after ECMO
the age of 16 initiation. All blood lactate on initiation of
weaning was longer in the
between Jan. cultures were
ECMO. ICU days and
infected cohort compared
2005 and
preferred to be done duration of mechanical
to the non-infected, but not
June 2011.
peripherally x2 or
ventilation before ECMO, significant (p=0.0845). Infrom central line if indication for renal
hospital mortality was not
146 total
access was difficult replacement therapy while statistically significant
ECMO
based on CDC
on ECMO.
(p=0.457)
patients were Guidelines.
analyzed. 96
Nearly 25% of ECMO
VA ECMO
patients in this study
patients and
experienced 1 or more
50 VV
nosocomial infections.
ECMO
patients.
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Purpose

Sample,
Setting
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Design, Framework Variables, methods for
measurement

Biffi, S., Di Bella, Literature
This literature Mixed methods
review was systematic review
S., Scaravilli, V., review of
articles
conducted
Peri, A. M.,
investigating using
All articles that
Grasselli, G.,
infectious
MEDLINE/ discussed
Alagna, L.,
complications PubMed
epidemiology,
Pesenti, A., &
of patients on research
etiology, risk factors
Gori, A. (2017).
ECMO to
database
and/or pathogenesis
Infections during
create an
using the
of infectious disease
extracorporeal
epidemiologica keyword
in the abstract were
membrane
l overview and ecmo OR ecls select regardless of
oxygenation:
identify
OR els OR study design,
epidemiology, risk underlying risk (extracorpore publication and
factors,
factors.
al AND
sample size
membrane
pathogenesis and
AND
Online publications
prevention.
oxygenation) of the ELSO
International
OR (life AND infectious disease
Journal of
support)
task force were also
Antimicrobial
considered.
Agents, 50(1), 9–
16.
Research for
doi:10.1016/j.ijanti
literature review was
micag.2017.02.025
updated last on
August 2, 2016.

Findings

Implications

Level of
Evidence

The following themes were Prevalence of hospital
Highlighted need for V
discovered in the literature acquired infections during a more standardized
review: incidence and
ECMO 10-12%., up to
approach to cannula
prevalence, impact of
20% in adult subgroup.
care for infection
infections on mortality rate
prevention
and ECMO complications, Prevalence and incidence
patient demographics/
of infectious episodes
Limitation is the age
characteristics, coamong adults range from of the research that
morbidities, clinical
9-65% and 12-75 cases per was reviewed. Last
severity, circuit
1,000 ECMO days
literature search was
configuration and
August 2016, but no
cannulation techniques,
Prevelance of blood stream limitation set on
duration of ECMO, etiology infections range from 3- earliest year for
of infection, preventative
18% and incidence ranges studies included.
practices and, antibiotic
from 2.98 to 20.55 per
Some research
usage on ECMO
1000 ECMO days
reviewed is from
1996.
Study by Steiner, et al.
Observed a three-fold risk
of death in patients
experiencing blood stream
infection during ECMO
treatment.
No studies were found that
analyzed implementation
of a dressing protocol or
cannula care “bundle
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Purpose

Sample,
Setting
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Design, Framework Variables, methods for
measurement

Bull, T., Corley, Compare the In vitro (test Quasi-experimental 13cm x 20cm pig skin
tube) in a lab cohort study
sample obtained
A., Smyth, D. J., use of
Dermabond
setting using
immediately after animal
McMillan, D.
Sample size of 18
was euthanized. The
J., Dunster, K. R., versus standard adult pig
adhesive
skins.
cannulated
pig
skins
samples were taken from a
& Fraser, J. F.
dressings
in
the
were
grouped
in
the
standard area of each pig.
(2018).
following
Location of following tubing
Sample encased in a metal
Extracorporeal
measures:
this study was securement cohorts: frame had a simulated
membrane
antimicrobial not published. 1) Grip-lok Universal ECMO site using 21F
oxygenation line- qualities,
securement device 2) venous canula. Standard
associated complic pullout
MultiFix Unifix
cannulation methods were
ations: in vitro
strength,
Universal Tube and practiced when placing
testing of
chemical
Catheter Securement cannula (use of dilators).
cyanoacrylate
compatibility to
and 3) Tensoplast
elastic adhesive
The tubing cohorts had
tissue adhesive and cannula
bandage
securement devices placed
securement devices
Compare
20cm away from the
to prevent
pullout strength
Second analysis was insertion site.
infection and
done to compare
dislodgement. Inte when using
Dermabond
Dermabond to
The Dermabond cohort for
nsive Care
compared to
adhesive dressings the insertion site segment
Medicine
sutureless
for insertion site
had 0.5mL of Dermabond
Experimental 6(6). securement
securement. Each
placed at the insertion site
Doi:
devices
cohort had 6 pig skin and under the cannula
10.1186/s40635samples.
extending ~7cm
018-0171-8
The force required to The adhesive only cohort
pull the cannula from for the insertion site
the skin was
segment had since layer of
measured and
Opsite 10cm x 17cm
compared.
covering cannula and left
untouched for 5 min.
Each skin was mounted
onto tensile testing machine
and pull-out force was
measured.

Findings

Implications

Dermabond significantly
increased pull-out force
required to remove
cannula from skin
compared to transparent
dressing (p<0.0001)

Grip-lok and Multifix III
may be feasible
securement for
tubing.

Grip-lok (92.0 N) device
and Multifix (94.8 N)
device required very
similar forces to remove
cannula securement
device, but were both
significantly higher
(p<0.01) forces than the
Tensoplast (56.2 N)

Dermabond is an
interesting approach,
concern that once
placed on insertion
site may cause
problems for skin.
Also, unable to
manipulate cannula
after it is placed on
site, as reversal agent
weakens cannula
integrity

Dermabond removal agent
significantly weakens the Need to note that this
cannula 1 h after exposure is not a human trial,
(p < 0.01)
and sample sizes are
very small, further
analyses required.

Level of
Evidence
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Purpose

Sample,
Setting
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Design, Framework Variables, methods for
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Bull, T., Corley, Investigate and Directors and Descriptive,
The following questions
compare
ECMO
qualitative survey
related to literature review
A., Lye, I.,
coordinators over one-month
were asked for each theme:
Spooner, A. J., & different
ECMO center’s from 396
period using
Fraser, J. F.
ECMO
SurveyMonkey.
Cannula dressing and
(2019). Cannula methods for
securing
and
centers
in
51
securement: frequency of
and circuit
dressing
countries that The following themes dressing change, sutured
management in
peripherally
were
were investigated:
securements, non-suture
peripheral
inserted ECMO members of center characteristics securements,
extracorporeal
cannulas
ELSO were and peripheral
Infection prevention:
membrane
invited to
cannulation methods, technique used for dressing
oxygenation: an
participate
infection prevention changes (sterile versus noninternational
for peripheral
sterile technique),
survey of 45
391
cannulation, cannula procedures for accessing
individual
dressing and circuit circuit, hand hygiene,
countries. Pubic
responses
access, cannula
preferred antiseptics
Library of Science
from
45
infection
14(12). Doi:
countries
surveillance, dressing Surveyors also asked if the
10.1371journal.pro
were
and line securement, facility had guidelines for
ne.0227248
collective.
circuit access,
cannula management and/or
181 responses guideline for ECMO written policy for bedside
from U.S., 32 line management
ECMO provider
from U.K.
practices

Findings

Implications

75% of facilities used
transparent, semipermeable dressings, of
this sample 21% used
CHG dressing and 15%
used CHG impregnated
disc. No centers left
dressings for > 7 days

Lack of standardized VI
policy for dressing
changes is
international issue

Securement: suturing to
skin most common (45%),
securing to bed/fixed
object (19%), sutureless
securement device (16%),
adhesive fabric tape
(10%).

No ECMO specific
sutureless securement
device commercially
available, forcing
bedside practitioners
to use alternative
securement devices.

ELSO recommends
fixation to at least 2
sites

34% of facilities reported Limitations – not
the occurrence of cannula ALL practices are
line/dislodgement or
represented, mostly
accidental decannulation at out of U.S. Also, data
their center in the last 5
dependent on selfyears. 61 centers reported reporting
that leading cause of
malposition, dislodgement
or decann was from
inadequate securement
78% of respondents
reported having a written
policy or guideline for
ECMO line management
CHG dressing products
(dressings and disks) used
at more than 50% of
responding facilities

Level of
Evidence
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Findings

Implications

Level of
Evidence

Corley, A., Lye, I., Investigate
Study
Prospective
Blood stream infection
Data analysis for this study Study could have a IV
prevalence of occurred over observational
define as at least one
began March 2019. Data huge impact on DNP
Lavana, J. D.,
12 month
positive blood culture OR has not yet been published project. Particularly
Ahuja, A., Anstey, nosocomial
the information
C. M., Jarrett, P., infections as period at 11 Trained investigators fever/chills and hypotension
at each facility
with at least 2 positive
regarding types of
Haisz, E., Parke, well as cannula ECMO
related
centers
across
screened
ECMO
blood
cultures
(from
dressing and methods
R., Pellgrine, V.,
infection.
Australia and patients for eligibility separate samples) with a
for securement and
Buscher, H., &
New Zealand. every week and
common skin contaminant
anchoring
Fraser, J. F.
This study is
completed a study- within 48h of symptoms
(2019).
currently under Adult,
specific care report
Nosocomial
progress,
pediatric and on each eligible
Surgical site infection
infection
purpose of
neonatal
patient.
(cannulation considered
prevalence in
article is to
ECMO
surgical site) includes
patients
generate
patients
The following data infection within 30 days
awareness of included in were collected on
after insertion and
undergoing
study and
study
eligible patients:
discontinuation of cannula
extracorporeal
potential
data
indication,
modality,
and one of the following:
membrane
points.
Goal
sample
dressing/securement,
purulent drainage from
oxygenation
size
for
this
presence
of
incision, organism isolation
(ECMO): protocol
study
is
120
suspected/confirmed
from insertion site,
for a point
patients
nosocomial infection pain/tenderness, swelling,
prevalence study
and antibiotic
redness at site, diagnosis by
across Australia
therapy.
surgeon or intensivist
and New Zealand.
British Medical
Patient inclusion
Secondary outcomes that
Journal Open,
criteria: Patients
will be measured: insertion
9(7), e029293.
undergoing ECMO site dressing, length of time
doi:10.1136/bmjop
treatment within last dressing was left on, tubing
48 hours, patients
securement methods and
en-2019-029293
decannulated from number of tubing fixation
.
ECMO >48 hours, points.
patients with
extracorporeal
support without an
oxygenator
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Glater-Welt, L. B., Survey
Survey went Observational,
16-question survey asking
descriptive
the following themes: type
Schneider, J. B., members of the out to all
correlational
of program (pediatric vs.
Zinger, M. M., ELSO registry ECMO
adult), number of cases per
Rosen, L., & about insertion directors at
institutions in 16-question survey to year, infection prevention
Sweberg, T. M. and
maintenance of the United
investigate practices bundle implementation,
(2016).
cannulas,
States that
for ECMO and
practices for accessing
Nosocomial
antibacterial
were ELSO infection prevention circuit, dressings over
bloodstream
prophylaxis
registered
at institutions in the insertion site and policy,
infections in
and infection
United States.
antibiotic prophylaxis, BSI
patients receiving surveillance
Survey was
rate for ECMO patients (%
extracorporeal life along with
emailed to
Survey used an email per year = # culture proven
support: variability associated
ECMO
format utilizing a
infection / # of cases per
in prevention infection rates. program
web-based
year)
medical
questionnaire.
practices: a survey
directors and
of the
coordinators
extracorporeal life
at 152
support
institutions.
organization
85 institutions
members. Journal
participated
of Intensive Care
(55%)
Medicine, 31(10),
654–669.
doi:10.1177/08850
66615571540

Findings

Implications

Level of
Evidence

27% of institutions used an Infection prevention IV
infection prevention
bundle is not well
bundle at time of
defined in this study,
cannulation (i.e. antibiotic but did not seem to
program).
have a significant
impact on BSI
82.9% of facilities reported
a “standard approach to
Researchers highlight
cannula dressings was
a large variability in
used”.
prevention practices
57.3% of institutions used Researchers state that
semi-permeable dressings the efficacy of a
standardized
60.49% of institutions
“bundle” approach to
reported changing cannula cannula care has not
dressings only when
been prospectively
soiled, 3.7% of facilities studied.
did not use a dressing.
ELSO discourages
As the size of the program use of routine
increased (# of cases),
prophylactic
bloodstream infections
antibiotics (excluding
increased (r = 0.52973, p < open chest) and
0.01).
surveillance cultures.
No correlation between
BSI and infection
prevention bundle
including antibiotics (p <
0.3997)
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Grigonis, A. M., To determine if A CVC
Cohort study.
a CLABSI
maintenance
Dawson, A. M.,
bundle
bundle was 30 LTACHs were
Burkett, M. K.,
Dylag, A., Sears, designed for an implemented selected out of 110
across 30
initially surveyed.
M., Helber, B., & acute-care
hospital
will
LTACHs.
A
Data was collected
Snyder, L. (2016).
have the same total number retrospectively to
Use of a central
reduction in
of 6,559
establish a baseline
catheter
CLABSI rates patients were analysis of CLABSI
maintenance
in a long-term analyzed for rates. Researchers
bundle in longacute-care
data-gathering collected data for 6
term acute care
hospital.
purposes after months.
hospitals. America
the study was Retrospective data
n Journal of
implemented was collected for 14
to contribute months prior to the
Critical
to the
implementation and
Care, 25(2), 165–
researchers’ LTACH CLABSI
172. doi:
statistical
rates were monitored
10.4037/ajcc20168
data.
for 14 months after
94
the study’s
implementation had
completed.

Findings

CLABSI bundle consisted CLABSI Standardized
of a bundled protocol,
Infection Ratio (SIR) prior
mandatory use of alcohol- to bundle implementation
based CVC caps, CHGwas calculated at 1.28
dressings, and the formation (95% CI 1.11-1.46) and
of a team of nurses that
post-implementation
oversee the CVC
equaled 0.96. (p= 0.01,
maintenance within the
95% CI 0.82-1.12).
LTACHs.
Researchers tested for staff
compliance by monitoring
items like CVC dressing
intactness and fully
occlusive, date present on
dressing, dressing initialed
by staff, dressing changed in
less than 7 days, daily
assessments of dressing
sites, and CHG-dressing in
place.

Implications

Level of
Evidence

Researchers proved IV
that CLABSI bundles
are just as effective
in reducing the rate
of CLABSIs outside
of a standard hospital
setting.
Ancillary findings of
this study showed an
increase in
compliance to
monitoring CVC
dressings and the,
overall, state of the
CVC.
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Hahne K,
Determine the
rate of ECMO
Horstmann C,
Fischer D, Köck R, cannula related
blood stream
Peters G, &
infections by
Lebiedz P.
conducting
Cannula-related
microbial
infection in adult
analysis of the
medical intensive
cannulas at the
care unit patients end of ECMO
undergoing
treatment and
extracorporeal life identify risk
support and
factors
extracorporeal
associated with
colinization.
membrane
oxygenation.
Journal of
Hospital Infection.
2015;91(4):372–
374.
doi:10.1016/j.jhin.
2015.08.022
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Medical ICU Observational, quasiat a university experimental
hospital
(location not At the end of ECMO
disclosed)
treatment, the
including all cannulas were
patients
sterilely
cannulated for discontinued, and the
ECMO Jan tips of each cannula
2013 to April were sent for
2015. Sample microbial analysis
size included
94 patients
and 186
cannulas (2
cannulas were
not available
for analysis)

Findings

Implications

Level of
Evidence

If a cannula related infection 15 patients were
Normal signs of
III
was suspected at the time of considered positive results bloodstream infection
decannulation, one the
for cannula related
are masked due to
central venous lines was
infection. (15.9%)
temperature control
also discontinued and
and inflammatory
cultured at the end of
The statistically significant response of
ECMO treatment
risk factors identified are cannulation, regular
pre-existing infection (p = blood cultures are
Cannula related infection 0.099, OR 0.389), and
recommended by
was assumed if microbial positive blood culture (p = researchers.
agent was found on both
0.010, OR 4.762)
cannulas, one cannula plus a
central line, or on a cannula Patients with an infection
plus a blood culture.
other than a bloodstream
infection had higher odds
The following potential risk of cannula related
factors were analyzed: age, infection (OR 2.0), but this
gender, pre-existing
was not statistically
infection, type of
significant (p = 0.292).
cannulation (emergent vs.
urgent), positive blood
culture, max SAPS II Score,
infection other than blood
stream infection during or
before ECMO therapy

ECMO CANNULA CARE BUNDLE
Reference

Purpose

Sample,
Setting

Marik, P. E.,
Flemmer, M., &
Harrison, W.
(2012). The risk of
catheter-related
bloodstream
infection with
femoral venous
catheters as
compared to
subclavian and
internal jugular
venous
catheters. Critical
Care
Medicine, 40(8),
2479–2485. doi:
10.1097/ccm.0b01
3e318255d9bc

A review of
Total sample
literature to
size
determine the consisting of
risk of catheter- 17,376
related
catheters
bloodstream
within
infections
randomized
related to
controlled
femorally
trials and
inserted non- cohort
tunneled
studies.
central venous
catheters when
compared to
subclavian and
internal jugular
(IJ) venous
catheters.
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Findings

Systematic review of
randomized
controlled trials and
cohort studies.

Two statistical outliers
Given statistical
I
were removed from
evidence, there
analysis of the relative risk should be no
between femoral and IJ
difference in
catheter-related
infectious risk
bloodstream infections
between ECMO
proved to have no
cannulae placed in
statistical difference (RR= the IJ and femoral
1.35, CI: 0.84-2.19 p=0.2). regions of the body.
Meta regression analysis
showed increased risk for
infection in earlier studies,
but not recent studies. This
implies that there is no
statistically significant
difference between
femoral CVC’s and those
placed in the subclavian
and IJ veins.

Trials selected included
relevant clinical trials that
compared the risk of
catheter-related blood
stream infections for CVCs
in the femoral vein,
compared to the IJ vein.
Data collected was for the
adult population and all
pediatric populations were
excluded.

Implications

Level of
Evidence
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Findings

Implications

Mitchell, M. L.,
Ullman, A. J.,
Takashima, M.,
Davis, C., Mihala,
G., Powell, M., …
Rickard, C. M.
(2019). Central
venous access
device securement
and dressing
effectiveness: The
CASCADE pilot
randomized
controlled trial in
the adult intensive
care. Australian
Critical Care, 1–
11. doi:
10.1016/j.aucc.20
19.10.002

This study to
tested three
dressing and
securement
methods for
central venous
catheters when
compared to a
control group.

Randomized
controlled
trial of 121
ICU patients
at an
Australian
hospital.

Randomized
controlled trial
between four groups
of dressings and
securement devices:
Sutures plus
chlorhexidine
gluconate (CHG)
dressing (control
group), control
group plus tissue
adhesive, two
suture-less
stabilization devices
plus CHG dressing,
and sutures, CHG
disk plus integrated
securement dressing.

RCT showed that highest
incidence rates (IR) of
line failure was in the
suture-less securement
device (IR= 27.3, CI=
11.4-65.6), then the
control group (IR= 22.3,
CI= 8.38-59.5), tissue
adhesive group (IR= 20.6,
CI= 6.66-64.0), and
finally the group using the
integrated securement
device (IR= 8.8, CI=
2.19-35.0).

CVC failure, in this II
study, is defined as
“any reason to
discontinue the
central line before
completion of
treatment”.

Study looked at skin
impairment comparing the
different adhesive
dressings. Microbiological
samples also showed an
increased number of
colonization despite CHG
impregnated dressings and
discs.

Rate of colonization
shows increased risk
for microbial
resistance to CHG.

Level of
Evidence
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Analyze the
Schmidt, M.,
Bréchot, N., Hariri, incidence and
S., Guiguet, M., impact of
Luyt, C. E., Makri, nosocomial
R., Leprince, P., infections on
Trouillet, J., Pavie, VA ECMO
patients and
A., Chastre, J., &
identify risk
Combes, A.
factors.
(2012).
Nosocomial
infections in adult
cardiogenic shock
patients supported
by venoarterial
extracorporeal
membrane
oxygenation.
Clinical Infectious
Diseases, 55(12),
1633–1641.
doi:10.1093/cid/cis
783

65

Sample,
Setting

Design, Framework Variables, methods for
measurement

Findings

VA ECMO
patients that
were placed
on ECMO for
refractory
cardiogenic
shock,
including
cardiac
surgical
patients.

Correlational, cohort ECMO site dressings were
study
changed every 2 days with
transparent dressing and
BSI defined as
cleansed with chlorhexidine
infections occurring solution.
>24 hours after
ECMO initiation and When cannula related
within 48 hours of
infections were suspected,
discontinuation.
needle aspirate was taking
Requires 2 or more at insertion site.
positive blood
cultures.
Blood cultures were taken
for suspected BSI and
Diagnoses of cannula venous catheter was
infection required
removed and cultured.
local signs of
infection at access
The following data was
site with positive
analyzed as potential risk
subcutaneous needle factor for BSI: patient
aspiration at insertion demographics,
site
comorbidities, SOFA score,
SAPS score II (both at
admission),
immunocompromised
status, reason for ECMO,
ICU days before ECMO,
location of cannulation, site
of cannulation, IABP use.

16 episodes of BSI per
1,000 ECMO days

Study took
place in a
cardiac ICU
in Paris,
France, total
sample size
included 220
patients
between Jan
2003 and Dec
2009.

Implications

Level of
Evidence

Researchers clustered IV
all nosocomial
infections when
Statistically significant risk analyzing the risk
factors for nosocomial
factors, therefore it is
infections are the
unknow if the same
following:
risk factors are
immunocompromised
related to BSI alone.
patients (p = 0.02), acute
myocardial infarction (p =
0.04), heart transplant (p =
0.007), patient cannulation
in the ICU (p = 0.006),
patient cannulation in the
cardiac catheterization lab
(p = 0.04).
64% of ECMO patients
developed a nosocomial
infection during ECMO
therapy.
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Silvetti, S.,
Ranucci, M.,
Pistuddi, V., Isgrò,
G., Ballotta, A.,
Ferraris, L., &
Cotza, M. (2019).
Bloodstream
infections during
post-cardiotomy
extracorporeal
membrane
oxygenation:
Incidence, risk
factors, and
outcomes. The
International
Journal of
Artificial Organs,
42(6), 299–306.
doi:10.1177/03913
98818817325

Assess the
incidence, risk
factors and
outcomes of
blood stream
infections in
adult and
pediatric
patients
supported with
VA ECMO
postcardiotomy.

IRCCS
Policlinica
San Donato
located in
Italy.

Retrospective
Prophylactic antibiotics
observational cohort were used in this
study.
population.

Findings

14 patients (15.2%)
developed a BSI during
defined ECMO-related
criteria – 24.7 BSI per
Patient factors that ECMO related BSI defined 1,000 ECMO days.
were analyzed: adult as a new positive blood
Patients on of pediatric, type of culture occurring from 48h Mortality in BSI patients
VA ECMO heart surgery,
after ECMO initiation or
was 50% and 23.1% in
postsurgical mortality
48h after discontinuation. those without BSI
cardiotomy risk pre-operatively,
(p=0.05)
from March time from surgery to
2013 to Dec. ECMO implantation,
No statistically significant
2017.
ECMO under eCPR,
difference in BSI in
serum creatinine and
peripheral vs. Central
Final sample bilirubin at the time
cannulation (p=0.811) nor
size included of ECMO
in the number of blood
92 patients. cannulation,
transfusions (p=0.960).
open/closed sternum
All patients post-operatively,
Serum bilirubin
received VA blood product
significantly higher in
ECMO due to transfusions.
patients that suffered BSI
inadequate
on ECMO (p=0.010)
cardiac output
following
surgery to
repair
congenital or
acquired heart
disease.

Implications

Level of
Evidence

Adult patients are
IV
more susceptible to
BSI than pediatric
patients in this study.
Highest recorded
CRI infection rate
found in literature
review despite this
population’s
requirement for
prophylactic
antibiotics.
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Discussion of
Spencer, T. R.
(2018). Securing appropriate
securement
vascular access
devices: using the methods for
right securement central access
catheters and
method can
the effects on
improve outcomes
patient
and reduce costs.
outcomes
American Nurse
Today, 13(9), 29–
31. Retrieved from
https://searchebscohostcom.wsuproxy.mn
pals.net/login.aspx
?direct=true&db=c
cm&AN=1317618
57&site=ehost-live
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No location Expert opinion
noted, expert
opinion
therefore no
sample
analyzed

The article discussed four
different methods for
securement of central lines:
Suture, adhesive dressings,
subcutaneous anchors and
cyanacrylate. Further
discussion under “findings”

Findings

Sutures: placed near
insertions site. Causes
barrier for adequately
cleaning beneath the
catheter

Implications

Level of
Evidence

Considerations were VII
made in this article as
to how timeconsuming
application was for
central line anchors.
Adhesives: quick, simple The writer believes
application. Strong
the rationale for
adhesives cause skin
sutures and adhesives
damage over time
as primary means for
line securement is
Subcutaneous: Anchor
due to the time
placed to subcutaneous
consuming nature of
tissue. Within 72 hours, other methods.
anchor heals into place.
Intended for long term
Interesting
CVC patients
preliminary data
discussed (not in
Cyanacrylate
detail) about the use
(Dermabond): new
of Dermabond for
method, little evidence
central lines,
although preliminary
although emphasized
studies are showing glue that further data is
may help inhibit gram + needed to further
organisms from entering analyze the risks and
the blood stream.
benefits of using
Requires solvent for
Dermabond routinely
removal.
for line securement
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Tignanelli, C. J., Review of
Weinberg, A., & optimal
Napolitano, L. M. techniques to
(2019). Optimal secure dual
methods to secure lumen cannula
(Avalon) to
extracorporeal
prevent
membrane
migration and
oxygenation
dislodgment
bicaval dual-lumen during activity
cannulae: what
and therapy.
works? American
Society for
Artificial Internal
Organs 65(6). Doi:
10.1097/MAT.000
00000000000853
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Location was
not disclosed.
Writers share
bedside
provider
experience
with of
Avalon
cannulas

Expert opinion

Findings

Implications

Level of
Evidence

No statistics were measured Hold-n-place leg band
Leg band technique VII
in this article. Writers
allowed for easier
seems to be
Writers compared
shared that the Hold-n-place assessment of the skin
innovative way to
experience of
leg band was preferred
around the head due to
anchor IJ cannula,
utilizing Coban for method for IJ cannula
Velcro strap.
but data based on
line securement to
securement.
patient experience,
30-inch Hold-n-Place
Hold-n-Place leg band
bedside provider
Leg band (intended
could be manipulated by experience and rates
for foley securement)
the bedside nurse, where of dislodgement or
as a headband.
Coban required two sets of migration before and
hands for proper
after implementation
placement and securement. of leg band would be
helpful to guide
Coban was requiring
practice
frequent replacement and
patients would complain of
headaches or discomfort
related to the necessary
tightness of the Coban
placement.
There was no statistical
analysis on patient
experience nor bedside
provider experience
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Timsit, J.-F.,
Bouadma, L.,
Ruckly, S.,
Schwebel, C.,
Garrouste-Orgeas,
M., Bronchard,
R., … Lucet, J.-C.
(2012). Dressing
disruption is a
major risk factor
for catheterrelated
infections*. Critic
al Care
Medicine, 40(6),
1707–1714. doi:
10.1097/ccm.0b01
3e31824e0d46

This study
observed the
correlation
between
frequent
central venous
catheter
(CVC) and
arterial line
dressing
removals or
disruptions,
and the rate of
insertion site
infections by
testing
regularly
scheduled
dressing
changes at 3
and 7 days,
respectively.

Sample size Double-blinded
for this study randomized
was 1,419
controlled trial.
patients
within 7
French
ICU’s.

This study’s research
indicates that extending the
scheduled dressing change
to 7 days for a CVC
decreases the risk for
insertion site colonization
for CVC’s. This study also
indicated that the severity
of organ failure for the
patient directly correlated
to an increase in dressing
disruptions and increased
risk for insertion site
infections.

Findings

Implications

Level of
Evidence

The number of dressing
disruptions is directly
related to rate of skin
colonization at insertion
site (p= <0.013).
Additional significant
items in study are the
greater the patient’s organ
failure, according to the
Sequential Organ Failure
Assessment (SOFA), the
greater the number of
dressing interruptions (p=
0.004).

Authors indicated
II
that they did not
assess the risk for
patient’s receiving
renal replacement
therapy and what
role decreased renal
function played
within this study.
Researchers alluded
that increased fluid
balance may also
increase dressing
disruptions.

ECMO CANNULA CARE BUNDLE
Reference

Purpose

Evaluates
Ullman, A. J.,
previous
Cooke, M. L.,
Mitchell, M., Lin, studies related
F, New, K., Long, to dressings
D. A., Mihala, G., and devices
& Rickard, C. M. used to secure
central venous
(2019). Dressings
catheters
and securement
(CVCs) to
devices for central assess which
venous catheters methods were
(CVC). Cochrane better at
Database of
decreasing
Systematic Reviews CLABSIs and
blood stream
(9). doi:
10.1002/14651858. infections
CD010367.pub2. (BSIs),
insertion site
infections, skin
colonization,
skin irritation,
and failed
catheter
securement.
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Cochrane
Systematic review of Quality of evidence rated
Library found 22 RCT’s. 9 studies moderate for CHG
22
involved gauze with impregnated dressings and
randomized transparent dressings, the risk for CLABSIs (RR=
controlled
6 compared CHG
0.65, CI= 0.40-1.05) and
trials
dressings for antihigh from the studies of
involving
microbial effect, 1
medication impregnated
7,436 patients compared silverdressings. (RR= 0.60, CI=
that were
impregnated
0.39-0.93). Two studies
relevant to the dressings, 1
evaluated the quality of
subject of
compared
securement of CVCs and
CLABSI and hydrocolloidal
showed no difference in
line
dressings, 1
sutured compared to
securement. compared standard sutureless securement
transparent dressings devices (RR= 1.20, CI=
to gas-permeable
0.55-2.63) with a low level
dressings, 1
of evidence.
compared highly
adhesive dressings to
CHG impregnated
dressings, and 1
compared transparent
dressings to sutureless securements.

Findings

Implications

Level of
Evidence

This systematic review of This review is
I
research indicates that
opposed to the Yu et
CHG and medicational. study.
impregnated dressings
lower the risk for
CLABSIs, when compared
to non-impregnated and
gauze dressings with a
moderate to high quality of
evidence.

ECMO CANNULA CARE BUNDLE
Reference

Purpose

Sample,
Setting

Analyze
Utilizing the
Vogel, A. M.,
ELSO
Lew, D. F., Kao, potentially
L. S., & Lally, K. modifiable risk registry, data
from 1987 to
P. (2011). Defining factors for
infections
2009 was
risk for infectious
complications
extracted for
complications on
acquired during all ECLS
extracorporeal life
extracorporeal patients
support. Journal of
life support
Pediatric Surgery (ECLS).
Sample size
46, 2260-2264.
included
doi:http://dx.doi.or
38,661 ECLS
g/10.1016/j.jpedsur
run from
g.2011.09.013
neonates to
adults.
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Design, Framework Variables, methods for
measurement

Findings

Implications

Retrospective,
Neonate, pediatric and adult
observational. Cohort risk factors for infectious
study
complications were
analyzed in three separate
The researchers
cohorts.
utilized data that had
previously been
Researchers compared
collected by ELSO cohorts in the type of
during this
complications including
timeframe. There
mechanical, renal,
was not a specified cardiovascular, metabolic
questionnaire
and double lumen catheters.
generated for this
ECLS durations and prestudy.
ECLS cultures were also
considered.
Infection
complication cohort
was compared to an
infection-free cohort.

Adult age population (OR
1.02, p<0.001),
longer duration of ECMO
therapy (OR 1.09, p =
0.002),
positive pre-ECLS culture
(OR 2.49, p<0.001),
are all associated with
increased risk for
infectious complications
on ECLS.

Traditional signs of IV
infections are masked
on a patient on
ECLS, making it
difficult to treat an
infectious
complication before
it becomes serious
(I.e. hypotension,
fever,
thrombocytopenia,
and significant
imaging).

Infectious complications
was associated with higher
mortality for ECLS
Data is reported to
patients.
ELSO on a voluntary
basis, causing
10.2% of patient
concern of underexperienced an infectious reporting of
complication on ECLS
infectious
complications.

Level of
Evidence
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Reference

Purpose

Sample,
Setting

Design, Framework Variables, methods for
measurement

Webster, J.,
Larsen, E., Marsh,
N., Choudhury,
A., Harris, P., &
Rickard, C.
(2017).
Chlorhexidine
gluconate or
polyhexamethylen
e biguanide disc
dressing to reduce
the incidence of
central-lineassociated
bloodstream
infection: a
feasibility
randomized
controlled trial
(the CLABSI
trial). Journal of
Hospital
Infection, 96(3),
223–228. doi:
10.1016/j.jhin.201
7.04.009

The purpose of
this study was
to test the
efficacy of
different antimicrobial
impregnated
discs (CHG
and PHMB) to
prevent central
line associated
blood stream
infections
(CLABSIs)

Sample size
was 100
patients in an
Australian
hospital.

Randomized
controlled trial.
Blinding was not
possible, per the
researchers, for this
study.

Single center study
conducted in tertiary
Australian hospital and not
confined to the ICU setting.

Findings

There appear to be no
difference in the amount
of CLABSIs when
comparing one antimicrobial disc to another.
Inclusion criteria for this
There apparent
study includes: consenting differences seem to be in
patients admitted and
how patient’s skin reacts
requiring a PICC line for at to the disc.
least three days and no
central line inserted during Two confirmed CLABSIs
their admission. Dressing reported by authors of this
changes were scheduled for study, one in each disc
every 7 days
group. Skin breakdown
beneath the disc was
reported in eleven patients
with higher reported
numbers in the PHMB
group, than the CHG
group (8 in PHMB and 3
in the CHG groups).

Implications

Level of
Evidence

CHG discs appear to II
decrease the risk of
skin breakdown for
patients requiring a
CVC, when
compared to the
alternative PHMBimpregnated disc.
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Reference

Purpose

Sample,
Setting

Design, Framework Variables, methods for
measurement

Findings

Implications

Wichmann, D. E.
B., Campos, C. E.
B., Ehrhardt, S. E.
B., Kock, T. E. B.,
Weber, C. E. B.,
Rohde, H. E. B.,
& Kluge, S. E. B.
(2018). Efficacy
of introducing a
checklist to reduce
central venous
line associated
bloodstream
infections in the
ICU caring for
adult
patients. BMC
Infectious
Diseases, 18(1).
doi:
10.1186/s12879018-3178-6

The purpose of
this study was
to evaluate the
use of
checklists with
CLABSI
bundles to
determine if
the addition of
a checklist
helps decrease
the prevalence
of CLABSIs.

The total
sample size
of this study
was n = 4416
ICU patients
in Hamburg
Germany
with 1518
patients in
the study
group and
2898 in the
control
group.

Observational cohort
study at a single
hospital center in
Hamburg, Germany
from 2011 to 2012.

The study reported a
decrease in the incidence
of colonization in the
checklist group when
compared to the control
group. 3.8 per 1000
catheter days in the
checklist group, compared
to 5.9 per 1000 catheter
days in the control group.
(IRR= 0.57, p= 0.0001)

More research is
IV
needed on the use of
checklists to
improve adherence
given that this was a
single research study
at a single location.

In patients with new
diagnoses of sepsis,
researchers mandated that 2
blood cultures be drawn
from peripheral sites and
the CVC explanted with tip
sent for microbiological
testing.
CLABSI is defined by the
researchers as positive
microbiological cultures
from the CVC tip and
blood cultures.

This study suggests that
the addition of a checklist
lowers the incidence of
Sepsis is defined by the
CLABSIs in ICU patient
Surviving Sepsis Campaign populations by improving
guidelines.
adherence to important
steps in the dressing
change process.

Level of
Evidence
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Reference

Purpose

Sample,
Setting

Design, Framework Variables, methods for
measurement

Findings

Implications

Yu, K., Lu, M.,
Meng, Y., Zhao,
Y., & Li, Z.
(2019).
Chlorhexidine
gluconate
transparent
dressing does not
decrease central
line‐associated
bloodstream
infection in
critically ill
patients: A
randomized
controlled
trial. International
Journal of
Nursing
Practice, 25(6),
1–8. doi:
10.1111/ijn.12776

This study
evaluates the
efficacy of two
transparent
dressings
(CHGpermeated and
non-CHGpermeated
dressings)
over central
line insertion
sites

Sample size
was 304
Medical ICU
patients in a
teaching
hospital in
Beijing.

Nonblinding
randomized
controlled trial.
Researchers
indicated that
blinding was not an
option for this study.

The study indicates that
there is no statistical
difference in CLABSI
rates when using a CHG
permeated transparent
dressing instead of a nonpermeated transparent
dressing. (X2= 0.028, p=
0.868).

This study has
II
several significant
limitations within
their study, like
length of the study,
that it was only at a
single hospital, with
a limited sample
size.

CLABSI rate is defined as
the number of infections
per 1000 catheter days.
CVCs were randomly
allocated to the
intervention and control
groups where subjects in
control group received
standard transparent
dressings and subjects in
the study group received a
CHG-impregnated
dressing.

Level of
Evidence

*Ackley, B. J., Swan, B. A., Ladwig, G. B., & Tucker, S. J. (Eds.). (2008). Evidence-based nursing care guidelines: Medicalsurgical interventions. St. Louis, MO: Mosby Elsevier.
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Appendix D

The Appraisal of Guidelines for Research & Evaluation Instrument (AGREE II) for the Clinical
Practice Guideline for the Prevention of Intravascular Catheter-Related Infections
Domain
Item
AGREE II Rating
1
2 3
4
5
6
7
Stron
Stro
gly
ngly
Disag
Agre
ree
e
1. Scope and 1. The overall objective(s) of the
KG
purpose
guideline is (are) specifically
MA
described.
Comments:
This guideline reviews multiple evidencebased strategies to decrease the risk for
CLABSI
The guideline’s objectives are clearly
defined within this CPG. The guideline
outlines these objectives and delivers
rationales founded on evidence.
2. The health question(s) covered by the
guideline is (are) specifically described.
Comments:
Although the guideline does not outright
list objectives as research questions for the
guideline, the health questions are implied
based on the evidence described.

KG MA

While I agree that the health questions are
not explicitly stated, the purpose of the
guideline is stated in the final paragraph of
the introduction, and the CPG outlines
various applications of preventing
CLABSIs for both adult, pediatric, and
neonate populations.
3. The population (patients, public, etc.)
to whom the guideline is meant to apply
is specifically described.
Comment:
The guideline visibly displays
recommendations and strategies for

KG
MA
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CLABSI reduction adult, pediatric, and
neonatal populations.
The CPG outlines its recommendations for
various patient populations that would
benefit from CLABSI reduction strategies.
2.
4. The guideline development group
Stakeholder includes individuals from all the relevant
involvement professional groups.
Comment:
Stakeholders are defined as the nursing
staff, nurse educators that will partake in
implementing protocols, patients with
central venous lines (CVC), and healthcare
systems.

KG
MA

Stakeholders are clearly outlined within the
CPG and defined as personnel involved in
the insertion and maintenance of
intravascular catheters.
5. The views and preferences of the
target population (patients, public, etc.)
have been sought.
Comment:
Every category explained has background
information to legitimize it’s use of
recommendations with systematic reviews
and meta-analyses.

KG
MA

The authors expand on each category by
including adult and pediatric/neonate
section within the category and the
implications for practice on each
population.
6. The target users of the guideline are
clearly defined.
Comment:

The guideline discusses any healthcare
personnel trained in the management of
invasive catheters can use this guideline
with their clinical care.

MA KG
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The CPG loosely defines the personnel
involved in the insertion and maintenance
of the CVCs; that being said, this is a
limited group of individuals.
3. Rigor of 7. Systematic methods were used to
development search for evidence.
Comment:
Research methods, databases used, and
keywords searched were not described.
Some information objectives had included
a rationale for recommendations but did not
include statistical evidence.

MA KG

No clear methodological evidence outside
an unclear 5-point scale was used by the
authors to show evidentiary quality.
8. The criteria for selecting the evidence
are clearly described.
Comment:
Each objective researched outlines a
recommendation followed by a rationale
for its recommendation.

MA KG

The criteria for selection and
implementation are loosely provided by the
authors by the summation of their reference
materials.
9. The strengths and limitations of the
body of evidence are clearly described.
Comment:
The guideline does not explicitly state any
limitations from the research
performed. Even though the material
denoted in the recommendations and
background rationale strengthens the
choice to implement strategies, they are not
explicit in stating strengths either.
The evidentiary strengths are listed by way
of a 5-point scale for recommending each
section for an implementation. The
limitations of this guideline are not listed.

MA

KG
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10. The methods for formulating the
recommendations are clearly described.
Comment:
Even though they created a sound
categorization for recommendations, there
were no specific methods or criteria
announced that needed to be met to include
studies in the evidence behind
interventions.
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KG
MA

The categorization of evidence is present,
but the authors did not outline how their
methods were founded.
11. The health benefits, side effects, and
risks have been considered in
formulating the recommendations.
Comment:
The benefits, side effects, and risks have
been well documented in the reasoning
behind prevention interventions.

KG
MA

The benefits of applying each article of the
CPG are described and expanded upon with
supporting evidence.
12. There is an explicit link between the
recommendations and the supporting
evidence.
Comment:
The guideline states the list of
recommendations, followed by rationale
and background for each category of
recommendations.

KG
MA

There is a link between the
recommendations and the evidence listed to
support it.
13. The guideline has been externally
reviewed by experts prior to its
publication.
Comment:
Several healthcare experts contributed to
creating this guideline, and the CDC states

KG
MA
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that external experts reviewed the guideline
before publication.
The contributing health experts to this CPG
is extensive and extends into the nursing,
medical, public health, and laboratory
science professions to provide increased
knowledge of the content at hand.
14. A procedure for updating the
guideline is provided.
Comment:
Within the guideline, the original publish
year was 2011, and there are multiple
"notice to reader" flags to alert the reader
that an update was done to the guideline
most recently in 2017.

KG
MA

Various areas within the CPG have been
updated already, and it should be expected
that more will follow.
4. Clarity of 15. The recommendations are specific
presentation and unambiguous.
Comment:
The recommendations are concrete in their
detail in caring for the insertion site of the
catheter and patient that has received the
line.

KG
MA

The recommendations are specific and
detailed in their description of evidence
within the CPG to outline what is or should
be, best practice for decreasing the rates of
CLABSI.
16. The different options for
management of the condition or health
issue are clearly presented.
Comment:
There are a variety of recommendations
that are tailored to various styles and
locations of CVCs
I would argue that this guideline is better
suited to prevent health issues when

KG MA
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applied as best practice. Given that this is
not a guideline used for the treatment of
disease-states, instead, it is used to prevent
disease-states from occurring.
17. Key recommendations are easily
identifiable.
Comment:
Recommendations are easily identified by
category throughout the guideline.
Key recommendations are easily
recognizable throughout the CPG.
5.
18. The guideline describes facilitators
Applicability and barriers to its application.
Comment:
Recommendations for each possible
intervention provide direction for the
reader to analyze barriers within their
facility. The writers of the guideline
discuss the need for ongoing education on
CLABSI prevention.

KG
MA

KG
MA

Barriers and facilitators to the application,
while not explicitly stated, can be inferred
upon by reading the individual sections and
establishing a facility-wide trajectory for
implementation to discover what may
hinder or make way for facility change.
19. The guideline provides advice and/or
tools on how the recommendations can
be put into practice.
Comment:
The guideline thoroughly explains the steps
and interventions required at each step of
dressing change and CVC insertion as well
as provides background for
recommendations.
The CPG explains and recommends how to
implement these guidelines into practice in
a descriptive manner.

KG
MA
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20. The potential resource implications
of applying the recommendations have
been considered.
Comment:
The resources that are recommended are
identified in the interventions that are
suggested to be implemented.

81
MA

KG

While some of the recommendations
provide a cost analysis for implementing
these measures into practice, overall, this is
not discussed in the CPG. The authors,
however, have described a step as "more
expensive," like when talking about
CHG/silver-impregnated CVCs.
21. The guideline presents monitoring
and/ or auditing criteria.
Comment:
The guideline has a specific section
devoted to performance improvement.
Within this section, the authors supply a list
of specific interventions necessary to
monitor for and prevent the incidence of
CRBSI.

KG
MA

The CPG provides auditing criteria for
facilities to use for quality improvement
measures.
6. Editorial 22. The views of the funding body have
independence not influenced the content of the
guideline.
Comment:
A systematic review was performed to
address any issues that were notable or
mentioned before publication.
The authors list any disclosures of CoI in
the acknowledgment section of the CPG
and disclose that an independent firm
provided this analysis to maintain
independence.

KG MA
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23. Competing interests of guideline
development group members have been
recorded and addressed.
Comment:
Within the acknowledgment section, there
is a disclosure of potential conflicts and
interests, including a list of organizations
and individuals who participated in certain
parts of the guideline (i.e., funding, etc.).

KG
MA

The authors list the disclosures CoI in the
acknowledgment section of the CPG.
Within it are various entities that may have
an impact on the impartiality of this work.
Overall
Guideline
Assessment

1. Rate the overall quality of this
guideline.

1
2
Lowe
st
possib
le
qualit
y

2. I would recommend this guideline for
Yes
use.
KG
Notes:
I recommend these guidelines but would
like to see an in-depth systematic review of
evidence that displays and strengthens the
rigor of this CPG.

3

4

5

6
7
KG High
MA est
possi
ble
quali
ty

Yes, with
No
modifications
MA
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Appendix F

Critical Appraisal of Systematic Review – CVC Dressings and Securement

Article Reviewed: Ullman, A. J., Cooke, M. L., Mitchell, M., Lin, F, New, K., Long, D.
A., Mihala, G., & Rickard, C. M. (2019). Dressings and securement devices for central venous
catheters (CVC). Cochrane Database of Systematic Reviews (9). Doi:
10.1002/14651858.CD010367.pub2.
Research Question
Does the review address a clearly Yes – there are several dressing and securement products
defined issue?
available for central lines, but it is not known which
products are most effective for CLABSI prevention.
Does the
The population
Yes – RCTs analyzing short- and long-term CVCs,
review
studied?
tunneled and non-tunneled, porta-a-caths, hemodialysis
describe the
lines, and peripherally inserted central catheters. The
following?
population includes any person of any age.
The intervention Yes – includes chlorhexidine impregnated dressings,
and/or treatment standard polyurethane dressings, silver-impregnated
given?
dressings, sterile gauze, and whether anchoring methods
were used.
The outcome(s)
Yes – to compare the available dressings and securement
considered?
devices for CVCs to identify which work best.
Is the review question clearly and Yes – “The objective of this research was to compare the
explicitly stated?
available dressings and securement devices for CVC’s to
identify what works best” (p. 2, 2019).
Literature Review
Were comprehensive search
methods used to locate studies?
Was a thorough search of
appropriate databases done?

Were other potentially important
databases observed?
Were the search methods
thoroughly described?
Were conclusions drawn about
the possible impact of publication
bias?
Were the overall findings
assessed for their robustness in

Yes – reviewers used electronic databases from eight
different sources and used 21 different combinations of
keywords in searches.
Yes – in addition to a thorough review of electronic
databases, the researchers also searched for clinical trials
related to CVC dressings by looking at seven different
databases.
Yes – the researchers stated they hand-searched
bibliographies of all retrieved and relevant publications
for further relevant studies.
Yes – Search methods and identification of studies were
very thoroughly discussed and described.
Yes – publication bias was assessed by teams of two
review authors, and data were cross-checked for accuracy
and agreement.
Yes – writers offer transparency in the rationale for
inclusion and exclusion of articles reviewed.
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terms of the selective inclusion or
exclusion criteria?
Study Selection
Were inclusion criteria for
selecting studies clearly described
and fairly applied?

Critical Appraisal
Was study quality assessed by
blinded or independent raters?
Was the validity of included studies
assessed?
Was the validity of studies assessed
appropriately?
Are the validity criteria reported?

Yes – two authors independently reviewed and retrieved
studies for relevance. The full versions of all articles
were reviewed by both reviewers and independently
selected for inclusion. Articles that both reviewers agreed
on were included, articles with discrepancies were
discussed between the reviewers with the consultation of
a third party to eliminate bias.
Yes – Quality was assessed by independent raters using
the Grading of Recommendations Assessment,
Development, and Education approach (GRADE)
No – this was not explicitly discussed.
No – this was not explicitly discussed.
No – this was not explicitly discussed.

Similarity of Groups and Treatments
Were reasons given for any
Yes – the reviewers assess heterogeneity of the
differences between individual
compared studies before meta-analysis
studies explored?
Are treatments similar enough to
Yes – researchers included several different types of
combine?
dressing for CVCs, and outcomes were measured in
CLABSI occurrences following the intervention.
Do the included studies seem to
Yes – the dressing chosen for each study was analyzed
indicate similar effects?
by the effect on CLABSI. The writers provide clear
criteria for what would be considered a positive
CLABSI.
If not, was the heterogeneity of effect Yes
assessed and discussed?
Data Synthesis
Were the findings from individual
studies combined appropriately?
Are the methods used to combine
studies reported?
Was the range of likely effect sizes
presented?
Were null findings interpreted
carefully?

Yes – although this meta-analysis provides a wide
variety of CVC dressing options.
Yes – since there are multiple dressing options
available, the reviewers used a Multiple Treatments
Meta-analysis (MTM)
Yes – effect sizes were reported for each article
reviewed
Null findings were not discussed, the article did not
explicitly state methods for reviewing null findings

ECMO CANNULA CARE BUNDLE

86

Were the methods documented?
Yes – methods were adequately explained.
Are review methods clearly reported? Yes
Summary of Findings
Is a summary of findings provided?
Are specific directives for new
research proposed?

Yes
Yes – suggested that researchers plan protocol to reduce
risk of bias, and clearly report trials and implementation
methods in research.
Are the recommendations based
“There was inadequate research to permit us to make
firmly on the quality of the evidence recommendations about CVC security using the
presented?
different dressing and securement products” (p. 32,
2019)
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Appendix G

Critical Appraisal of Systematic Review – CVC Location Related to Risk for Infection

Article Reviewed: Marik, P. E., Flemmer, M., & Harrison, W. (2012). The risk of catheterrelated bloodstream infection with femoral venous catheters as compared to subclavian and
internal jugular venous catheters. Critical Care Medicine, 40(8), 2479–2485. doi:
10.1097/ccm.0b013e318255d9bc
Research Question
Does the review address a clearly defined
Yes – the article researches whether CVCs
issue?
inserted in the femoral vein have a higher risk
for CRBIs than CVCs inserted in the internal
jugular or subclavian veins.
Does the
The population studied
Yes – the review specifies that adult patients
review
were participating in RCTs and cohort studies
describe the
between the years of 1966 to 2011 all patients
following
received non-tunneled CVCs as a method of
treatment during their hospitalization.
The intervention and/or
Yes – CVCs were inserted in the two RCTs
treatment given
documented in the systematic review. Both
RCTs are French studies that documented the
difference in CRBIs between subclavian and
femoral CVC insertions and internal jugular and
femoral CVC insertions.
The outcome(s) considered Yes – consideration for the differences in
CRBIs depending on whether the CVC was
inserted into the subclavian, femoral, or internal
jugular vein.
Is the review question clearly and explicitly Yes – The review question was explicitly
stated?
stated, “to determine the risk of catheter-related
bloodstream infections related to non-tunneled
central venous catheters inserted at the femoral
site as compared to subclavian or internal
jugular placement.”
Literature Review
Were comprehensive search methods used to
locate studies?

Was a thorough search of appropriate
databases done?

Questionable – Medline and Google were
used with nine different subject headings and
keywords. The authors stated that Google was
utilized to search for results in non-peerreviewed journals.
Yes – The authors used EMBASE, and
Cochrane Review databases were included in
their review of data.
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Were other potentially important databases
observed?
Were the search methods thoroughly
described?
Were conclusions drawn about the possible
impact of publication bias?

Were the overall findings assessed for their
robustness in terms of the selective inclusion
or exclusion criteria?

Study Selection
Were inclusion criteria for selecting studies
clearly described and fairly applied?

Critical Appraisal
Was study quality assessed by blinded or
independent raters?
Was the validity of included studies assessed?

Was the validity of studies assessed
appropriately?
Are the validity criteria reported?

Similarity of Groups and Treatments
Were reasons given for any differences
between individual studies explored?

88
Yes – The authors reviewed the
bibliographies of all articles obtained until no
new articles could be found for review.
Yes – the article discusses in detail the
process for search and selection of articles for
data retrieval.
Yes – the reviewers compiled the articles into
a funnel plot to assess for publication bias and
found some degree of publication bias within
the articles selected in the review.
Yes – The authors discuss in detail their
process for selecting articles based on the
quality of data reported in the original
articles.
Yes – Two authors gathered data from
relevant studies based on a standardized form,
and data was retrieved based on study design,
size, setting, patient population, number of
catheters at each insertion site, number of
catheter days, number of CRBIs, and
frequency of DVTs reported.
No – There was no indication made in the
review that the study quality was blinded or
assessed by independent raters.
Questionable – While inclusion tables were
included outlining the inclusion and exclusion
criteria for final inclusion and the review
outlines how the two authors independently
reviewed for inclusion criteria, there was no
expansion to digital academic search engines
outside and databases of Medline, EMBASE,
and Cochrane Review.
No – Expansion on the validity of the study's
appropriateness was not mentioned.
Yes – The criteria mentioned to assess for
validity are mentioned by the authors in the
Study Selection and Data Extraction section.
Yes – Heterogeneity was assessed for the
studies chosen in the review. Two outliers
were identified that, when removed, also
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Are treatments similar enough to combine?

Do the included studies seem to indicate
similar effects?
If not, was the heterogeneity of effect
assessed and discussed?

89
eliminated the heterogeneity within the
review.
Yes – Once the two studies were identified,
the treatment appeared similar enough to
combine.
Yes – The included studies indicate a similar
effect.
Yes – Two included studies contributed to the
heterogeneity of the studies within the review.
Once identified, the authors note that
heterogeneity was removed.

Data Synthesis
Were the findings from individual studies
combined appropriately?

Yes – findings were combined appropriately
and according to study type (cohort and
RCT). It should be noted that the authors
discovered that the age of study impacted the
rate of CRBI prevalence and that the
incidence decreased over time.
Are the methods used to combine studies
Yes – The methods that the authors used for
reported?
combining the studies were reported in detail.
Was the range of likely effect sizes presented? Yes – the ranges of effect sizes are detailed
within the review.
Were null findings interpreted carefully?
No – Null findings were not mentioned in the
review.
Were the methods documented?
Yes – The methods were documented within
the review.
Are review methods clearly reported?
Yes – The review clearly reports the findings
of the articles reviewed with findings reported
clearly and abundantly.
Summary of Findings
Is a summary of findings provided?
Are specific directives for new research
proposed?

Are the recommendations based firmly on the
quality of the evidence presented?

Yes – A summary of findings is provided.
No – The authors do not propose that further
research is needed to corroborate their review
and recommend that femoral-insertion of
CVCs are a safe alternative to subclavian and
internal jugular vein CVCs.
Yes – The recommendation that the usage of
femoral-inserted CVCs is a safe alternative is
based firmly on the quality of evidence
presented within this review.
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Appendix H

Cost Analysis for ECMO Cannula Site Care Bundle
Product – current practice
Central line dressing kit:
• 4x4 Tegaderm (3M)
• Cavilon swab (3M)
• Chlorhexidine stick (Prevantics)
• 3-line caps
• Sterile drape (3M)
• 2x2 gauze (Covidien)
• 4x4 gauze (Covidien)
• Biopatch CHG-impregnated disc
• Sterile gloves
• Surgical mask (3M)
Chlorhexidine swab (Prevantics)
4x10 Tegaderm (3M)
Stat-lock w/ tie down (Maquet)
Hollister vertical tube attachment (Optional)
TOTAL

Product – desired practice OPTION 3
4X6 Tegaderm with CHG (3M)
2 Chlorhexidine sticks (Prevantics)
Cavilon swab (3M) need 2
Bioderm CathGrip Securement Device
4x4 gauze (Covidien)
Sterile drape
Sterile gloves
Surgical mask (3M)
TOTAL
**Verified contract pricing for the facility

Cost
• $ 0.48**
• $ 0.75**
• $ 1.70
• $ 6.72
• $ 0.99**
• $ 0.04
• $ 0.10
• $ 5.99
• $ 1.43
• $ 0.24**
$ 1.70
$ 1.073**
$ 6.00
$ 9.99
$27.21 with Maquet anchor
$31.20 with Hollister anchor

Cost
$ 5.96**
$ 3.40
$ 0.75**
$ 9.96**
$ 0.10
$ 0.99
$ 1.43
$ 0.24**
$ 23.58
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Appendix I

Johns Hopkins Model Implementation Plan for ECMO Cannula Site Bundle

PET Management Guide

PRACTICE QUESTION
Step 1: Recruit interprofessional team
Step 2: Define the problem
Step 3: Develop and refine the EBP question
Step 4: Identify stakeholders
Step 5: Determine responsibility for project leadership
Step 6: Schedule team meetings

EVIDENCE
Step 7: Conduct internal and external search for evidence
Step 8: Appraise the level and quality of each piece of evidence
Step 9: Summarize the individual evidence
Step 10: Synthesize overall strength and quality of evidence
Step 11: Develop recommendations for change based on evidence synthesis
• Strong, compelling evidence, consistent results
• Good evidence, consistent results
• Good evidence, conflicting results
• Insufficient or absent evidence

TRANSLATION
Step 12: Determine fit, feasibility, and appropriateness of recommendation(s) for
translation path
Step 13: Create action plan
Step 14: Secure support and resources to implement action plan

ECMO CANNULA CARE BUNDLE
Step 15: Implement action plan
Step 16: Evaluate outcomes
Step 17: Report outcomes to stakeholders
Step 18: Identify next steps
Step 19: Disseminate findings

© 2017 The Johns Hopkins Hospital/ Johns Hopkins University School of Nursing
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Appendix J

Checklist for Cannula Site Care Protocol
For all peripherally inserted ECMO Cannulas (RIJ and Femoral)

Dressing Change Timing:
ECMO Cannula Insertion sites should be changed:
• Every 7 days
• Every 2 days if gauze or hemostatic dressing is in place
• Immediately if the dressing is soiled or no longer intact

Equipment needed
Please ensure you have the following supplies:
❑
❑
❑
❑

Central line dressing kit
BioDerm Cath Grip
4”x 6” CHG impregnated Tegaderm
IF TWO CANNULAS IN SAME
SITE - 1 Prevantics swabstick
❑ 1 Cavilon barrier film
❑ IF NEEDED – One (1) 4” x 10”
Tegaderm

❑ 1 Cavilon barrier film
❑ IF NEEDED – One (1) 4” x 10”
Tegaderm

Procedure
On other side

***PLEASE return this completed form to Kelly Garaffa’s mailbox for ALL
peripheral ECMO dressing changes from [DATE] to [DATE]***
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Procedure:
❑ Obtain an “ECMO Cannula Site Care Kit” from supply room and ensure products listed
above are present.
❑ Disinfect workspace with Chlorhexidine. (I.e. bedside table or counter space)
❑ Perform hand hygiene, open the first portion of the central line kit, which is non-sterile.
❑ Don mask and clean gloves.
❑ Assess if clipping/hair removal is indicated – if so, pull back dressing keeping insertion
site covered by at least 2.5cm radius. Clip any hair that has grown as necessary.
❑ Carefully remove soiled or outdated dressing without contaminating the area under the
dressing.
❑ Visually inspect insertion site for redness, drainage, swelling, or signs of infection.
❑ Inspect insertion site stitch, if stitch is no longer intact – notify attending physician
immediately.
❑ Doff clean gloves, perform hand hygiene, and don new pair of clean gloves.
❑ Clean insertion site and surrounding skin (an area approximately the size of the dressing)
with Prevantics swabstick. Place one flat side of the foam tip to the skin and prep the
skin in vigorous back-and-forth repeated strokes for 1 minute. Turn the swabstick over
(unused side of the foam tip) and repeat procedure by prepping for 1 minute. Allow the
prepped area time to dry for 1 minute. Do not blot, fan, or wipe dry. If there are two
cannulas at same insertion site, do not use the same Prevantics. Repeat this step
with a new Prevantics over next site.
❑ Remove gloves and perform hand hygiene.
❑ Open sterile portion of the kit on a clean, flat surface. Sterilely drop the 4” X 6” CHG
impregnated Tegaderm onto the field.
❑ Don sterile gloves.
❑ Apply Cavilon skin protectant around insertion site, do not get closer than 4cm around
insertion site. Allow 30 seconds to dry.
❑ Apply CHG impregnated Tegaderm over site making certain the edges are smooth and
adherent to the patient.
❑ Label the dressing with date/time/initials:
▪ *FEMORAL CANNULA* 9-12 inches away from insertion site, swab barrier film, once
dry place anchor on thigh.
▪ *IJ CANNULA* below patient’s opposite collarbone swab barrier film, once dry place
anchor.
❑ Document in ECMO flowsheet the dressing change, reason for dressing change, insertion
site assessment and all interventions completed.

Performed by: _________________________________________________
Date:_________________
Patient sticker:
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Appendix K

Post-implementation Survey
(This is a draft of what will be generated utilizing survey monkey)
How many years of experience do you have?
[Fill in the blank]
How many years of ECMO experience do you have?
[Fill in the blank]
Which of the following is true about the ECMO Cannula Site Care bundle?
The ECMO Cannula Site Care Bundle simplified the dressing change process
It made my workflow more difficult
It did not change my workflow
It improved my workflow easier
Which of the following is true about the BioDerm CathGrip anchor?
The BioDerm anchor prevent movement of the cannula more adequately than previous
methods
The BioDerm anchor provides the same amount of support as previous anchoring
methods
The BioDerm anchor provides less support than previous anchoring methods
Which of the following is true regarding the CHG impregnated dressing?
The CHG dressing provides adequate cannula coverage, not requiring reinforcement
The CHG dressing is does not adequately cover the dressing, requiring the use of
additional dressings
The CHG dressing provides the same coverage as the tegaderm used previously.
Which of the following are true when comparing the CHG coverage in the dressing compared to
the biopatch?
The CHG segment has better contact to the insertion site compared to the biopatch
The CHG segment does not make adequate contact to the insertion site, the biopatch is a
better product for the ECMO patient.
The CHG segment provides the same contact to the insertion site compare to the biopatch
Which of the following is true regarding skin integrity with the new dressing method.
There was more skin breakdown related to the new dressing practice
There was less skin breakdown related to the new dressing practice
There was the same amount of skin breakdown in both dressing practices
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The ECMO cannula site care bundle provides adequate supplies for sterilely cleaning the cannula
insertion site when compared to previous dressing methods.
True
False
[Comment box]
Which of the following are the most common reasons for changing an ECMO cannula site
dressing? (Select all that apply)
Bloody/saturated
Dressing not intact
Dressing lasted 7 days, requiring change
The dressing was removed for a procedure (ex. Cannula advancement, replacing sutures,
etc.)
Please provide any additional comments below:
[Comment box]
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Appendix L

Peripheral ECMO Preliminary Confounding Data
TIMELINE: June 1, 2019 – June 1, 2020
Patient populations: All peripheral ECMO patients with the following cannulation sites:
• Right internal jugular vein
• Right femoral vein
• Right femoral artery
• Left femoral vein
• Left femoral artery
Exclude all patients that have any central cannulation sites (i.e. open chest, left ventricular vent)
ECMO site flowsheet data:
• Number of days on ECMO, number of hours
• Number of times there was a “circuit change”
• Number of dressing changes
• Reason for dressing change (saturated, not intact)
• Veno-Veno (2 venous insertion sites) or Veno arterial (1 venous, 1 arterial
insertion site)
Location that patient was cannulated:
• OR
• CV Lab
• Bedside
• Outside hospital
Patient data:
•
•
•
•
•
•

Age
Gender
Admitting diagnosis (unsure if able to get this, or need to chart review?)
Number of vent days before cannulation
APACHE Score – unknown if we track this?
Survival to discharge?

Infection control data:
• Positive blood cultures during ECMO therapy
o Include 48 hours after ECMO is discontinued
o Include 48 hours after ECMO is initiated
• Positive CLABSI during ECMO therapy and 48 hours after
• If positive blood cultures during ECMO therapy, what was the organism?
Sentinel events:
• Cannula dislodgement

